Vanadate-induced cell cycle regulation and its signal transduction pathway by Zhang, Zhuo
Graduate Theses, Dissertations, and Problem Reports 
2002 
Vanadate-induced cell cycle regulation and its signal transduction 
pathway 
Zhuo Zhang 
West Virginia University 
Follow this and additional works at: https://researchrepository.wvu.edu/etd 
Recommended Citation 
Zhang, Zhuo, "Vanadate-induced cell cycle regulation and its signal transduction pathway" (2002). 
Graduate Theses, Dissertations, and Problem Reports. 1655. 
https://researchrepository.wvu.edu/etd/1655 
This Dissertation is protected by copyright and/or related rights. It has been brought to you by the The Research 
Repository @ WVU with permission from the rights-holder(s). You are free to use this Dissertation in any way that is 
permitted by the copyright and related rights legislation that applies to your use. For other uses you must obtain 
permission from the rights-holder(s) directly, unless additional rights are indicated by a Creative Commons license 
in the record and/ or on the work itself. This Dissertation has been accepted for inclusion in WVU Graduate Theses, 
Dissertations, and Problem Reports collection by an authorized administrator of The Research Repository @ WVU. 
For more information, please contact researchrepository@mail.wvu.edu. 
DISSERTATION 
 
 
VANADATE-INDUCED CELL CYCLE REGULATION AND ITS SIGNAL 
TRANSDUCTION PATHWAY 
 
 
 
Zhuo Zhang 
 
 
 
Dissertation submitted to the 
School of Pharmacy 
At West Virginia University 
In partial fulfillment of the requirements 
for the degree of 
 
 
Doctor of Philosophy 
In 
Pharmaceutical Sciences 
 
 
Xianglin Shi, Ph.D., Chair 
Vincent Castranova, Ph.D. 
Daniel C. Flynn, Ph.D. 
Robert L. Haining, Ph.D. 
Yongyut Rojanasakul, Ph.D 
Val Vallyathan, Ph.D. 
 
 
Department of Basic Pharmaceutical Sciences 
 
Morgantown, West Virginia 
 
2002 
 
 
 
Keywords: vanadate, cell cycle, reactive oxygen species (ROS), MAP kinase, 
p53, p21, PI-3 kinase, PKB/Akt, p70 S6 kinase 
ABSTRACT 
 
Vanadate-induced Cell Cycle Regulation and its Signal Transduction Pathway 
 
Zhuo Zhang 
 
Vanadate is potent toxic and carcinogenic agent. The mechanisms of its toxic and 
carcinogenic actions are still under investigation. Cell cycle arrest is an important 
mechanism in maintaining genomic stability and integrity in response to environmental 
stress. The present study investigated the possible mechanisms involved in vanadate-
induced cell cycle arrest and its signal transduction pathway. The results show that 
vanadate caused G2/M phase arrest A549 cells. p21 and cdc25C affected on cyclin 
B/cdc2 complex, resulting in the cell cycle arrest at G2/M phase. p38 and extracellular 
signal-regulated protein kinase (ERK) were involved in the regulation of these cell cycle 
regulatory proteins. Furthermore, reactive oxygen species (ROS), especially, hydrogen 
peroxide (H2O2), mediated vanadate-induced G2/M phase arrest. The effect of p53, a 
tumor suppressor gene, also was examined in the present study. It has been shown that 
vanadate-induced S phase arrest was dependent on p53 through p21 pathway. Both p38 
and ERK acted as upstream regulators of p53. However, the role of p53 is both phase- 
and cell line-specific. Vanadate-induced G2/M phase arrest is p53-independent in mouse 
embryo fibroblasts. It has been reported that phosphatidylinositol-3 kinase (PI3K) and its 
down stream kinases, protein kinase B (PKB)/Akt and p70 S6 kinase (p70S6K) play an 
essential role in control of transcription and protein synthesis, which impact on cell 
growth, survival and metabolism. The present study investigated the effects of these 
kinases on vanadate-induced cell cycle arrest and its regulation. It has been found that 
vanadate activated both PI3K and Akt, which in turn caused hyperphosphorylation of 
retinoblastoma protein (pRb) and increased E2F1 expression. Induction of E2F1 activated 
cyclin E which triggered G1/S transition. Vanadate was also able to cause 
phosphorylation of p70S6K through PI3K-dependent pathway. Activation of p70S6K 
affected on p21, and cdc25A, leading to inactivation of cdk2. Therefore, inactivation of 
cdk2 caused the cells being unable to progress from S to G2 phase. The present study 
provides a molecular basis for understanding the mechanisms of vanadate-induced 
cellular responses, and furthers understanding of the carcinogenic process induced by this 
metal. 
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1OVERVIEW 
 
Vanadium is widespread in the environment and is a trace metal in biological 
systems. It exists in water, rocks, and soil in low concentrations and in coal and oil 
deposits in relatively high concentrations. Vanadium is widely found in mining, steel and 
steel-alloy making, and in the chemical industry. In the periodic table, vanadium belongs 
to the first transition series and can form compounds in valences III, IV and V. The 
vanadium (III) species are unstable at physiological pH and in the present of oxygen. 
Vanadium (IV) is easily oxidized to vanadium (V) under physiological conditions and 
vanadium (V) species are found as vanadate anions. Workers occupationally exposed to 
vanadium are at risk as respirable particulates may penetrate deep into the pulmonary 
tract. Epidemiological studies have shown a correlation between vanadium exposure and 
the incidence of lung cancer in humans (1, 2). While the mechanisms of vanadium’s 
toxicity and carcinogenicity remain to be investigated, it has been reported that this metal 
is able to regulate growth factor mediated signal transduction pathways, promote cell 
transformation, exert inhibitory effect on certain enzymatic systems, and decrease cell 
adhesion (3-5). Vanadium compounds were also reported to cause direct DNA damage 
such as strand breaks and hydroxylation of dG residues (6), activate certain transcription 
factors, such as AP-1 (7), NF-B (8), p53 (9) and nuclear factor of activated T cells 
(NFAT) and induce apoptosis (10,11). 
 
Phosphotyrosine phosphatases (PTPs) serve as important regulators of cellular 
signal transduction pathways. PTPs are sensitive targets of oxidative stress and may be 
inhibited by treatments that induce intracellular oxidation (12). The PTP inactivation 
under oxidizing conditions that amplified by the redox-linked activation of key protein 
tyrosine kinase (PTKs) leads to the initiation of phosphotyrosine-signaling cascades that 
are no longer under normal receptor control (12). These ligand-independent signals 
result in the accumulation of protein phosphotyrosine, the generation of second 
messengers, the activation of downstream kinases, and the nuclear translocation of 
2nuclear factors kappa B (NF-κB) (12). Vanadium compounds have been widely used as 
PTP inhibitors, and their efficiency has been demonstrated in animal models and human 
clinical trials of insulin-resistant diabetes mellitus (13). It has been reported that reactive 
oxygen species (ROS) are involved in downstream signaling between PTPase inhibition 
and NF-κB activation (14). As an insulin-mimetic agent, peroxovanadate promoted 
glucose transport, and activated both phosphatidylinositol 3-kinase (PI3K) and Akt in 
adipocytes (15). It is believed that peroxovanadate functions by inhibiting tyrosine 
phosphatase, which results in an increase in the level of tyrosine phosphorylation of 
many signaling proteins, thus triggering signaling pathways normally regulated by 
growth factors (16). The activation of signaling pathways and the induction of related 
genes by oxidative stress can alter the functional development of affected cells, leading 
to such diverse outcomes as cellular proliferation and apoptosis (17). In addition, it has 
been found that pervanadate induced tyrosine phosphorylation of the platelet-derived 
growth factor (PDGF)-beta receptor, interaction of the phosphorylated PDGF receptor 
with extracellular signal-regulated kinase (ERK) activation and DNA synthesis (18). The 
contribution of both tyrosine phosphatase inhibition and oxidative stress of these effects 
has not been established. The current understanding suggests that both two factors may 
be important. 
 
Proliferation and cell cycle progression are functionally linked to the expression 
of genes associated with growth control. Both cause and effect relationships between the 
factors that modulate the cell division cycle exist, reflecting multidirectional signaling 
between segments of regulatory cascades that operate selectively in specific cells and 
tissues. The integration of positive and negative regulatory signals is appreciated in a 
broad spectrum of biological contexts. These include: (a) repeated traverse of the cell 
cycle for cleavage divisions during the initial stages of embryogenesis and continued 
renewal of stem cell population; (b) stimulation of quiescent cells to proliferate for tissue 
remodeling and wound healing; and (c) exit from the cell cycle with the option to 
3subsequently proliferate or terminally differentiate. The important is an appreciation of 
the cell regulatory mechanisms that are compromised in transformed and tumor cells and 
in non-malignant disorders, where there are abnormalities in cell cycle and/or growth 
control (19). The cornerstone for investigations into mammalian cell cycle control is the 
documentation by A. Howard and S. R. Pelc, nearly five decades ago, that proliferation 
of eukaryotic cells requireds discrete periods of DNA synthesis (S phase) and mitotic 
division (M) with a postsynthetic, premitotic period designated G2 and a postmitotic, 
presynthetic period designated G1. The ability of cells to maintain genomic integrity is 
vital for cell survival and proliferation. Lack of fidelity in DNA replication and 
maintenance can result in deleterious mutations leading to cell death or, in multicellular 
organisms, cancer (20). Signal transduction pathways play a key role in the regulation of 
cell cycle progression and stabilization of DNA under genotoxic stress. Cell-cycle 
checkpoints control the onset of DNA replication and mitosis in order to ensure the 
integrity of the genome (21, 22). Since vanadate is a DNA damaging agent and a 
carcinogen, the cells may undergo growth arrest upon exposure to this metal to prevent 
the cells with damaged DNA from proliferation. Thus investigation of vanadate-induced 
cell cycle arrest is an important for understanding the overall mechanism of vanadate-
induced carcinogenesis. 
 
Role of MAPKs and ROS in vanadate-induced cell cycle arrest (Section I) 
 
Recent advance indicates that reactive oxygen species (ROS) may function as 
intracellular messengers to modulate signaling pathways (23, 24). The changes of 
intracellular ROS have been detected in a variety of cells stimulated with cytokines, 
growth factors and agonists of receptors (25, 26). Various studies have demonstrated that 
many protein kinases and transcription regulatory factors are activated under the 
conditions of oxidative stress (24, 27-31). Mitogen-activated protein kinases (MAPKs) 
cascades are protein kinase signal transduction pathways that have been remarkably 
conserved in evolution. They are differentially used to relay numerous extracellular 
4signals within cells (32-34). These MAPK cascades have been found to be involved in 
such diverse cellular functions as proliferation, differentiation, stress responses, and 
apoptosis. Stress-activated protein kinases (SAPK)/Jun N-terminal kinase (JNK), p38 and 
extracellular signal-related kinase (ERK), are the most widely studied members of 
MAPK family. Recent studies have shown that ROS can activate MAPK (29-31), leading 
to abnormal M phase transition in the cell cycle (35). Oxidative stress may be a biological 
outcome of the p38 MAPK-mediated spindle checkpoint arrest that has been 
demonstrated by microinjection of active p38 or by nocodazole treatment in Xenopus 
embryos and mouse cells (36). It has been reported that under oxidative stress, cycling 
cells will exhibit cell cycle checkpoint response (37, 38). It has been demonstrated that 
vanadate-mediated generation of ROS plays an important role in its adverse biological 
effects (39, 40).  
 
Using the human alveolar epithelial cell line, A549, the present study investigates 
the role of ROS and ERK and p38 protein kinase in vanadate-induced cell growth arrest. 
Exposure of cells to vanadate led to cell growth arrest at the G2/M phase and caused up-
regulation of p21 and phospho-cdc2 and degradation of cdc25C in a time- and dose-
dependent manner. Vanadate induced activation of MAPKs family members, ERK and 
p38, as determined by their phosphorylation. PD98059, an inhibitor of ERK, and 
SB202190, an inhibitor of p38, not only decreased phosphorylation of ERK and p38 in 
response to vanadate, but also inhibited vanadate-induced cell growth arrest, up-
regulation of p21 and cdc2 and degradation of cdc25C. Cellular reduction of vanadate 
generated hydroxyl radical (COH) as determined by electron spin resonance (ESR), and 
superoxide radical (O2C-) and hydrogen peroxide (H2O2) as determined by flow cytometry 
and confocal microscopy using specific dyes. Generation of O2C- and H2O2 was inhibited 
by specific antioxidant enzymes, superoxide dismutase (SOD) and catalase, respectively. 
It can be concluded that ROS activate ERK and p38, which in turn up-regulate p21 and 
cdc2 and cause degradation of cdc25C leading to cell growth arrest at G2/M phase.  
5Specific ROS affect different MAPK family members and cell growth regulatory proteins 
with different potencies. 
 
Role of p53 in vanadate-induced cell cycle arrest (Sections II and III) 
 
 p53 is important for securing the stability and integrity of the genome of normal 
cells and was suggested to be the ‘guardian of the genome’ (41). A variety of DNA 
insults were shown to stabilize the protein, which in turn can either cause growth arrest, 
permit the induction of the DNA repair process, or alternatively, direct cells to undergo 
apoptosis (42). p53 was suggested to be a sensor of damaged DNA, and be involved in 
the repair process (43). The p53 tumor suppressor is a multifunctional protein that exerts 
a variety of different effects and plays a central role in the regulation of the normal cell 
cycle (44, 45). 
 
It has been reported that both p53-dependent and p53-independent pathways are 
involved in the cell cycle regulation (46). p53-dependent cell growth arrest in G1 phase is 
an important component of the cellular response to stress. Recent study indicates that p53 
controls the entry into mitosis when cells enter G2 phase with damaged DNA or when 
they are arrested in S phase due to depletion of the substrates required for DNA synthesis 
(47). p21 (WAF-1/CIP1) is known to be a transactivation target of p53, and is believed to 
mediate p53-induced growth arrest triggered by DNA damage (48, 49). Induction of p21 
expression could serve as an indicator for transactivation by p53, although p21 was also 
shown to be transactivated by p53-independent mechanisms (50). 
 
The present study investigated the regulation of p53 on vanadate-induced S 
phase arrest using both p53 wild type C141 cells and p53 deficient embryo fibroblasts 
(p53 -/-). On vanadate stimulation, C141 cells exhibited a dose- and time-dependent S 
phase arrest as determined by DNA content analysis. In contrast, vanadate was unable to 
increase the percentage of S phase in p53 -/- cells. Luciferase assay showed that 
6vanadate induced p53 activation in a dose- and time-dependent manner in p53 wild type 
C141 cells. Addition of pifithrin-α (PFT), a specific inhibitor of p53, reduced the 
activation of p53 with a concomitant decrease in growth arrest at S phase. Western 
blotting analysis demonstrated that vanadate caused a dose- and time-dependent increase 
of p21 level in C141 cells. Pretreatment of C141 cells with PFT decreased p21 
expression induced by vanadate while the p21 expression did not vary in vanadate 
stimulated p53 -/- cells. The results obtained from the present study suggest that 
vanadate is able to induce S phase arrest through p53 and p21-dependent pathway. 
 
 The present study also investigated the role of p53 in vanadate-induced G2/M 
phase arrest and its regulation, two cell lines, normal mouse embryo fibroblasts (p53 +/+) 
and p53 deficient mouse embryo fibroblasts (p53 -/-), were used in the present study. The 
results show that in p53 -/- cells vanadate induced G2/M phase arrest in a dose- and time-
dependent manner without alteration of S phase. In p53 +/+ cells, vanadate treatment 
increased S phase with no significant change at G2/M phase. Furthermore, Western 
blotting results show that in p53 -/- cells vanadate caused cdc25C degradation and 
activation of phospho-cdc2 without alteration of p21 level. In p53 +/+ cells, vanadate 
increased expression of p21 and degraded cdc25A instead of cdc25C without any effect 
on cdc2. These results demonstrate that vanadate induced G2/M phase arrest in p53 
deficient mouse embryo fibroblasts, and caused S phase arrest in p53 wild type mouse 
embryo fibroblasts. 
 
Interaction of MAPKs and p53 in vanadate-induced cell cycle arrest (Section IV) 
 
The p53 tumor suppressor protein appears to serve numerous functions during the 
cellular response to genotoxic stress, some of which act as a transcription factor to 
activate gene expression (51). p53 is considered an important mediator in the cell cycle. 
Various kinases including double-stranded DNA-activated protein kinase (DNA-PK), 
cyclin A and cyclin B-associated kinase cdc2, ERK and JNK have been implicated in p53 
7phosphorylation that in turn participates in regulation of p53 activity (6, 7, 52). It has 
been reported that p53 activation correlated with prominent activation of ERK1/2 MAP 
kinases that resulted from colcemid-stimulated development of focal adhesions that 
caused G1 phase arrest (53). In addition, phosphorylation of p53 by p38 plays a role in 
p53-dependent transcription (37). 
 
The present study investigated the involvement of MAP kinases in vanadate-
induced cell growth arrest and the relationship of p53. DNA content analysis showed that 
vanadate induced S phase arrest is time- and dose-dependent in p53 wild type C141 cells 
but not in p53 deficient C141 cells. Western blotting results indicated that vanadate caused 
an inactivation of p-cdk2 at Thr160, which is an important kinase for the progression of S 
phase, and an increase in expression of p21, which is a key for S phase arrest. In p53 
deficient cells, vanadate did not induce any observable change in p21 or p-cdk2 level. In 
addition, vanadate up-regulated phospho-p38 and ERK, two members of MAP kinases. At 
the same time, vanadate increased the p53 activity as measured by luciferase assay. 
Addition of PD98059 and SB202190, inhibitors of ERK and p38, respectively, decreased 
vanadate-induced S phase arrest, reduced p21 level, restored activation of p-cdk2, and 
decreased p53 activity. The study demonstrated that vanadate-induced S phase arrest is 
mediated by both ERK and p38 in p53–dependent pathway. 
 
Involvement of E2F1-pRb in vanadate-induced cell cycle arrest through Akt 
pathway (Section V) 
 
Mammalian cells require an extracellular proliferative signal directly after mitosis 
in order to keep on growing and dividing. When cells are faced with a lack of such a 
signal, they will either die or go into growth arrest in a postmitotic G1 phase. One of 
important intracellular signaling pathways that transduce such proliferative signals is PI3K 
pathway (54). The proto-oncogene protein kinase (PKB), known as Akt, is a major target 
8of PI3K signaling in the control of cell proliferation, as it is involved in anti-apoptotic 
signaling as well as cell cycle control (55). 
 
Although the mechanisms by which PKB contributes to the regulation of 
apoptosis have become better defined, relatively little is known concerning its role in the 
regulation of cell cycle progression (55). A recent study has demonstrated that the cell-
cycle regulator E2F is a component of the downstream proliferative machinery regulated 
by Akt (56). One of the key events in G1 phase is the activation of E2F, which in turn 
binds to promoters and trans-activates various genes critical for cell cycle progression, 
such as cyclin E (55). The E2F family of transcription factors are important regulators of 
the G1/S cell cycle transition, because E2F can activate expression of the S phase 
regulatory genes necessary for initiating DNA replication (57). E2F is a repressor when 
complexed with a member of the retinoblastoma (Rb) family of pocket proteins (58, 59). 
The continuation of cell proliferation at various stages of the cell cycle involves 
inactivation of at least one of three members of the Rb family (54). The pRb protein is an 
essential component of the G1/S checkpoint (60). pRb is present at relatively constant 
levels throughout the cell cycle but is hyperphosphorylated by cyclin/cdk complexes and 
released from E2F1 at the G1/S transition, allowing continuation through the cell cycle 
(61). 
 
The present study shows that in normal C141 cells, vanadate treatment increased 
percentage of the cells at S phase and elevated cyclin E and cyclin A expression. 
Vanadate treatment triggered phosphorylation of pRb and release of E2F1. Furthermore, 
vanadate increased both Akt kinase activity and caused phosphorylation at Ser473 and 
Thr308. Inhibition of Akt by either inhibitors or transfected cells with dominant negative 
kinase mutant or dominant negative phosphorylation mutant decreased the percentage of 
the cells at the S phase induced by vanadate, and reduced both cyclin E and E2F1 
expression and phosphorylation of pRb. The present study indicates that Akt plays an 
essential role in vanadate-induced S phase arrest and transition from G1 to S phase 
9through E2F-pRb pathway. 
 
The role of PI3K and p70S6K in vanadate-induced cell cycle arrest (Section VI) 
 
One of the important downstream targets of PI3K is p70 S6 protein kinase 
(p70S6K). The importance of this kinase at a molecular level is that it is involved in the 
selective translational regulation of a unique family of mRNAs, by mediating the multiple 
phosphorylation of 40S ribosomal protein S6 (62). These mRNAs encode for components 
of the translational apparatus, including ribosomal proteins and translational elongation 
factors whose increased expression is essential for cell growth and proliferation (63). 
 
The present study investigated the role of PI3K in vanadate-induced cell cycle 
arrest in C141 mouse epidermal cells. Vanadate caused a dose-dependent increase in p21 
and decrease in both cdc25A and cdk2. In ∆p85 cells, vanadate did not alter these cell 
cycle regulatory proteins. Vanadate caused a time- and dose-dependent increase in PI3K 
activity through phosphorylation of p70 S6 kinase (p70S6K) at Thr421/Ser424 and 
Thr389 sites. The phosphorylation at these sites was inhibited both by PI3K inhibitor, 
LY294002, and p70S6K mutation. Moreover, vanadate induced S phase arrest was 
inhibited by LY294002 and rapmycin, a p70S6K inhibitor. Vanadate-induced S phase 
arrest was also inhibited in transfection with dorminant negeative p70S6K mutant cells. 
In these cells, vanadate-induced activation of p21 and the degradation of cdc25A and 
cdk2 were inhibited. Taken together the results obtained show that vanadate is able to 
increase PI3K activity through phosphorylation. PI3K activated p70S6K, which 
phosphated protein S6 and controlled the cell cycle regulatory proteins and blocked 
vanadate-induced cell cycle arrest at S phase. 
10
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SECTION I 
 
 
Vanadate Induces Cell Growth Arrest through MAPKs  
and Reactive Oxygen Species 
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I.1. ABSTRACT 
 
Cell growth arrest is an important mechanism in maintaining genomic stability 
and integrity in response to environmental stress. Using the human alveolar epithelial cell 
line, A549, the present study investigates the role of reactive oxygen species (ROS) and 
extracellular signal-regulated protein kinase (ERK) and p38 protein kinase in vanadate-
induced cell growth arrest. Exposure of cells to vanadate led to cell growth arrest at the 
G2/M phase and caused up-regulation of p21 and phospho-cdc2 and degradation of 
cdc25C in a time- and dose-dependent manner. Vanadate stimulated mitogen-activated 
protein kinases (MAPKs) family members, as determined by the phosphorylation of ERK 
and p38. PD98059, an inhibitor of ERK, and SB202190, an inhibitor of p38, not only 
decreased phosphorylation of ERK and p38 in response to vanadate, but also inhibited 
vanadate-induced cell growth arrest, up-regulation of p21 and cdc2 and degradation of 
cdc25C.  Cellular reduction of vanadate generated hydroxyl radical (COH) as determined 
by electron spin resonance (ESR), and superoxide radical (O2C-) and hydrogen peroxide 
(H2O2) as determined by flow cytometry and confocal microscopy using specific dyes. 
Generation of O2C- and H2O2 was inhibited by specific antioxidant enzymes, superoxide 
dismutase (SOD) and catalase, respectively.  ROS activate ERK and p38, which in turn 
up-regulate p21 and cdc2 and cause degradation of cdc25C leading to cell growth arrest 
at G2/M phase.  Specific ROS affect different MAPK family members and cell growth 
regulatory proteins with different potencies. 
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I.2. INTRODUCTION 
 
Vanadium is an essential transition trace element found in some plants and 
animals.  It is widely distributed in rocks, soil, and to a lesser extent in water (1-3).  
Vanadium compounds (V(V)) exert potent toxic effects on a wide variety of biological 
systems (1,4-8).  This metal regulates growth factor mediated signal transduction 
pathways, promotes cell transformation and decreases cell adhesion (9-11).  Occupational 
exposure to vanadium occurs in mining, petrochemical industries and coal and oil fired 
plants. Epidemiological studies have shown a correlation between vanadium exposure 
and the incidence of lung cancer in humans (6,8,12,13).  Vanadium compounds were 
reported to modify DNA synthesis and repair (14-16).  Vanadate induced forward 
mutations and DNA-protein crosslinks in cultured mammalian cells (17).  While the 
biochemical mechanism of vanadium carcinogenicity is still not fully understood, recent 
studies have indicated that vanadium-mediated generation of reactive oxygen species 
(ROS) may play an important role (18-26). For example, through ROS, vanadium caused 
2'-deoxyguanosine hydroxylation and DNA damage (26), apoptosis (27,28), and 
activation of nuclear transcription factors (21), AP-1 and NF-κB (29). 
 
In mammalian cells, cell cycle transition is under the control of a tightly regulated 
network of cell division kinases (cdks) and a number of surveillance mechanisms, the so-
called checkpoints (30).  In most normal cells DNA damage arrests proliferation in G1/S 
or G2/M phase and then resume proliferation after the damage is repaired (30).  The cell 
cycle controls the onset of DNA replication and mitosis in order to ensure the integrity of 
the genome (31-33).  Lack of fidelity in DNA replication and maintenance can result in 
deleterious mutations, leading to cell death or, in multicellular organisms, cancer (30). 
 
Recent advance indicates that ROS may function as intracellular messengers to 
modulate signaling pathways (34,35). The changes of intracellular ROS have been 
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detected in a variety of cells stimulated with cytokines, growth factors and agonists of 
receptors (35-37). Various experiments provide evidence that many protein kinases and 
transcription regulatory factors are activated under the conditions of oxidative stress 
(35,38-42).  Mitogen-activated protein kinases (MAPKs) cascades are protein kinase 
signal transduction pathways that have been remarkably conserved in evolution.  They 
are differentially used to relay numerous extracellular signals within cells (43-45).  These 
MAPK cascades have been found to be involved in such diverse cellular functions as 
proliferation, differentiation, stress responses, and apoptosis.  Stress-activated protein 
kinases (SAPK)/Jun N-terminal kinase (JNK); p38 and extracellular signal-related kinase 
(ERK) are the most widely studied members of MAPK family.  Recent studies have 
shown that ROS can activate MAPK (40-42), leading to abnormal M phase transition in 
the cell cycle (46).  Oxidative stress may be a biological outcome of the p38 MAPK-
mediated spindle checkpoint arrest that has been demonstrated by microinjection of 
active p38 or by nocodazole treatment in Xenopus embryos and mouse cells (47).  
Although ROS are frequently mentioned in the literature to be inducers for MAPKs, 
many of the studies are indirect, for example, N-acetylcysteine (NAC) was used as an 
inhibitor (48).  The link between ROS and cell growth arrest is not yet eatablished.  Many 
questions remain to be answered.  For example, (a) do ROS play a key role in induction 
of cell growth arrest; (b) which species among ROS are involved; (a) are MAPKs 
involved  in ROS-mediated cell growth arrest; (d) do ROS affect cell growth regulatory 
proteins.  In the present study, vanadate was used as an inducer of ROS because this 
metal is capable of generating a whole spectrum of ROS, i.e., H2O2, O2•-, and •OH in the 
stimulation of the cells.  ESR, confocal microscopy and flow cytometry, Western blotting 
in combination with various specific antioxidants were used in the present study to 
investigate the role of ROS induced by vanadate in ERK and p38 kinase signal 
transduction pathway in cell growth arrest. 
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I.3. MATERIALS AND METHODS 
 
Chemicals   Sodium metavanadate and 5,5-dimethyl-1-pyraline-N-oxide (DMPO) 
were purchased from Aldrich (Milwaukee, WI).  RNase A and superoxide dismutase 
(SOD) were from Sigma (St. Louis, MO).  Catalase was from Roche Molecular 
Biochemicals (Indianapolis, IN).  Propidium iodide (PI), 2’, 7’-dichlorofluorescin 
diacetate (DCFH-DA), dihydroethidium (HE), and tetramethylrhodamine-5-(and-6-)-
isothiocyanate (TRITC) were from Molecular Probes (Eugene, OR).  Both F12K nutrient 
mixture medium and fetal bovine serum (FBS) were from Gibco BRL (Life 
Technologies, Gaithersburg, MD). PD98058 and SB202190 were from Calbiochem (San 
Diego, CA). Antibodies to p21 and cdc25C were from Santa Cruz Biotechnology (Santa 
Cruz, CA).  Antibodies to p38, ERK, and phospho-cdc2Tyr15 and second AP linked anti-
rabbit IgG were from Cell Signaling (Beverly, MA).  The spin trap, DMPO, was purified 
by charcoal decolorization. DMPO solution, thus purified, did not contain any ESR-
detectable impurities. 
 
Cell culture   The human alveolar epithelial cell line, A549, was cultured in F12K 
nutrient mixture medium containing 10% FBS, 2 mM L-glutamine and 1000 U/ml 
penicillin-streptomycin in an incubator at 5% CO2 and 37°C. 
 
Measurement of cell cycle/DNA content   DNA content in G1/S, G2/M phase was 
detected using flow cytometry (49,50).  A549 cells were fixed and permeabilized with 
70% ice-cold ethanol for more than 2 h, and incubated with the freshly prepared staining 
buffer (0.1% Triton X-100 in PBS, 200 µg/ml RNase A, and 20 µg/ml PI) for 15 min at 
37°C.  Cell cycle analysis was performed by flow cytometry with at least 10,000 cells for 
each sample.  The histogram was abstracted and the percentage of cells in the G1/S and 
G2/M phase was then calculated using ModFit LT software. 
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Western blotting analysis   Whole cell extracts were mixed with Tris-Glycine 
SDS sample buffer and then subjected to Tris-Glycine gel electrophoresis.  The resolved 
proteins were transferred to a PVDF membrane.  Western blotting was performed using 
antibodies against p21, cdc25C, phospho-cdc2Tyr15, p38, ERK and second anti-rabbit IgG. 
After reaction with ECF substrate, the signal was detected using a Storm Scanner 
(Molecular Dynamics, Sunnyvale, CA). 
 
Electron spin resonance (ESR) measurements   ESR spin trapping was used to 
examine free radical generation.  This technique involves an addition-type reaction of a 
short-lived radical with a diamagnetic compound (spin trap) to form a relatively long-
lived free radical product, the so-called spin adduct, which can be studied by 
conventional ESR (51).  The intensity of the spin adduct signal corresponds to the 
amount of short-lived radicals trapped, and the hyperfine splittings of the spin adduct are 
generally characteristic of the original, short-lived, trapped radical.  
 
All measurements were conducted using a Varian E9 ESR spectrometer and a flat 
cell assembly as described previously (52,53).  The relative radical concentration was 
calculated by multiplying one half of the peak height by (∆Hpp)2, where ∆Hpp represents 
peak-to-peak width.  A549 cells were mixed with DMPO to a total final volume of 0.5 
ml.  The reaction mixture was transferred to a flat cell and measurements were made after 
10 min. 
 
Cellular hydrogen peroxide (H2O2) and superoxide anion (O2•-) assay   Both flow 
cytometry and confocal microscopy were used to measure the generation of H2O2 and O2•-
.  DCFH-DA is a specific molecular probe for H2O2, and HE is specific dye for O2•-.  The 
principle of this assay is that DCFH-DA diffuses through the cell membrane and is 
enzymatically hydrolyzed by intracellular esterases to non-fluorescent dichlorofluorescin 
(DCFH).  In the presence of H2O2, this compound is rapidly oxidized to highly 
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fluorescent dichlorofluorescein (DCF) (54,55).  HE, a blue fluorescent dye, is oxidized to 
ethidium that stains nucleus a bright fluorescent red (27).  TRITC is an important 
fluorophore for preparing protein conjugates (56). A549 cells were cultured in 6-well 
plates containing 5×105 cells in each well. The cells were treated with 100 µM vanadate 
for 1 h.  DCFH-DA or HE (final concentration, 5 µM) was added to the cells and 
incubated for another 15-20 min prior to measurement of fluorescence.  Cells were 
harvested, washed twice with PBS, and then analyzed using flow cytometry.  For the 
confocal analysis of H2O2, DCFH-DA was added to the cells together with 2.5 µM 
TRITC for 15-20 min prior to the measurement.  TRITC was used as another dye to 
observe the presence of the cells because DCFH-DA is colorless unless it is oxidized by 
H2O2.  For the confocal analysis of O2•-, only He was used because this dye itself 
exhibited fluorescent blue. 
 
Oxygen consumption assay   The reaction mixtures contained 1×106/ml cells and 
100 µM vanadate. Oxygen consumption was determined using a Gilson oxygraph 
equipped with a Clark eletrode. The oxygraph was calibrated with medium equilibrated 
with oxygen of known concentrations.   
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I.4. RESULTS 
 
Effect of vanadate on the cell cycle   DNA content was measured by flow 
cytometry to investigate vanadate-induced cell growth arrest. Human alveolar epithelial 
cells, the A549 cell line, were exposed to vanadate for 24 h with various concentrations 
of vanadate.  The results show that after 24 h exposure, 100 µM vanadate caused growth 
arrest (45.24%) at G2/M phase (Figure 1).  Figure 1A shows the time dependence of 
vanadate-induced G2/M phase arrest.  At a vanadate concentration of 100 µM, vanadate-
induced G2/M phase arrest peaked at 24 h. Effects of vanadate concentration in the ranges 
of 10-200 µM were examined after a 24 h exposure.  An increase in vanadate 
concentration increased the percentage of G2/M phase (Figure 1B). 
 
Effect of vanadate on cell growth regulatory proteins   Several cell growth 
regulatory proteins, p21, phospho-cdc2 and cdc25C were examined by Western blotting. 
The results are shown in Figure 2.  Treatment of the A549 cells with 100 µM vanadate 
for different times increased the levels of both p21 and phosphorylated cdc2 (left panel).  
Treatment of the cells with 100 µM vanadate for 6 h slightly increased the cdc25C level.  
An increase in incubation time caused degradation of cdc25C and further exposure of the 
cells to 48 h completely degraded cdc25C. 
 
The dose dependent effects of vanadate on these three growth regulatory proteins 
were also examined.  As shown in Figure 2 (right panel), vanadate caused a dose-
dependent increase in the levels of both p21 and phosphorylated cdc2. 25 µM vanadate 
caused degradation of cdc25C and 100 µM almost completely degraded this regulatory 
protein. 
 
Activation of MAPK induced by vanadate The influences of vanadate on the 
phosphorylation of ERK and p38 were examined by Western blotting using antibodies 
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specific for the phosphorylated MAPKs in A549 cells.  Exposure of the cells to vanadate 
stimulated the phosphorylation of both ERK and p38 (Figure 3).  The phosphorylation 
was relatively rapid and remained high level from 1 h to 4 h for both ERK and p38 (left 
panel). To study the dose dependence of the phosphorylation of both ERK and p38, A549 
cells were treated for 4 h with various concentrations of vanadate.  A dose-related 
increase in both ERK and p38 phosphorylation was observed in the cells treated with 
increasing concentrations of vanadate from 10 µM to 200 µM (right panel). 
 
Inhibition of vanadate-induced activation of ERKs and p38   In the previous two 
sections, we have demonstrated that vanadate is able to stimulate phosphorylation of both 
ERK and p38.  In this section, we examined the inhibitory effect of PD98059 and 
SB202190 on vanadate-induced activation of ERK and p38. As shown in Figure 4, 
pretreatment of the cells with PD98059 before vanadate exposure (100 µM for 4 h) 
inhibited vanadate-stimulated phosphorylation of ERK. A similar inhibition of p38 
phosphorylation was observed with SB202190. 
 
Effect of ERK and p38 on vanadate-induced cell growth arrest   ERK and p38 
may affect vanadate-induced cell growth arrest through a signal transduction network.  
To test the role of ERK and p38 in vanadate-induced growth arrest, the A549 cells were 
exposed to 100 µM vanadate for 24 h and cell cycle arrest was monitored by flow 
cytometry.  As shown in Figure 5, exposure of the cells to vanadate caused cell growth 
arrest with 45.24% of the cells being retained in G2/M phase.  For examination of the role 
of the ERK in vanadate-induced cell growth arrest, the cells were pretreated with 
PD98059, a specific MEK1-ERK pathway inhibitor, before exposure of cells to vanadate.  
The results show that pretreatment of the cells with PD98059 resulted in a marked 
inhibition of vanadate-induced cell growth arrest, decreasing the percent of cells in G2/M 
phase to 35.34% for 50 µM PD98059 and 31.08% for 100 µM PD98059, respectively. 
Pretreatment of the cells with SB202190, a specific inhibitor of p38 also inhibited 
vanadate-induced cell growth arrest, decreasing the percent of cells in G2/M phase to 
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25.58% for 5 µM SB202190 and 19.00% at 10 µM SB202190, respectively.  Both of 
these two inhibitors alone had no effect on cell cycle, the G2/M phases stayed the same as 
control (data not shown).  These results indicate that both ERK and p38 are involved in 
vanadate-induced cell growth arrest. 
 
Inhibition of ERK and p38 inhibitors on cell growth regulatory proteins To 
further show that vanadate-induced cell growth arrest is mediated by ERK and p38, we 
examined the effects of PD98059 and SB202190 on vanadate-induced p21 and phospho-
cdc2 levels and degradation of cdc25C.  As shown in Figure 6, pretreatment of the cells 
with PD98059 or SB202190 decreased the levels of p21 and phospho-cdc2.  Both of 
these two inhibitors also partially blocked the degradation of cdc25C observed after 
vanadate exposure.  
 
Hydroxyl radical (•OH) generation induced by vanadate It has been 
established that vanadate-mediated generation of ROS plays an important role in many 
cellular responses.  For example, ROS generated by vanadate are involved in vanadate-
induced DNA damage (26), activation of AP-1 and NF-κB (29), and apoptosis (52, 54). 
Using ESR spin trapping with DMPO as a spin trap, we examined vanadate-induced •OH 
generation.  The use of a spin trap is necessary due to the reactive nature of the free 
radicals to be studied.  This method is specific and sensitive and is considered to be the 
preferred one for detection and identification of free radical generation.  As shown in 
Figure 7a, cells alone generated a very weak signal.  A mixture of cells and vanadate 
generated a relatively strong signal displaying a 1:2:2:1 quartet with aH = aN = 14.9 G 
(Figure 7b), where aH and aN represent hyperfine splittings of the nitroxyl nitrogen and β-
hydrogen, respectively, indicative of a DMPO/COH adduct. The detection of a 
DMPO/COH adduct indicates COH radical generation.  Addition of sodium formate, an 
COH radical scavenger and DMPO competitor, decreased the intensity of the DMPO/COH 
adduct signal and resulted in the appearance of a new spin adduct signal with the splitting 
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constants aH = 18.7 and aN = 15.7 G, which is indicative of a DMPO/ CCOO- adduct 
(Figure 7c).  The generation of a CCOO- radical was due to the abstraction of a hydrogen 
atom from formate by the COH radical, a confirmation of COH radical generation from 
vanadate-stimulated cells.  Catalase, on the other hand, abolished the DMPO/ COH adduct 
signal (Figure 7d), indicating that (a) H2O2 is an important precursor for vanadate-
induced COH radical generation; and (b) H2O2 is generated in vanadate-stimulated cells. 
 
Generation of H2O2 and O2C- by vanadate-stimulated cells   Flow cytometry and 
ROS dye were used to measure H2O2 and O2C- generated by vanadate-stimulated cells. 
Although selective dyes (DCFH-DA for H2O2 and HE for O2C-) were employed, it is still 
possible that these dyes may not be totally specific. To overcome this potential problem, 
various specific antioxidants were used in combination with the dye staining to determine 
specificity.  As shown in Figure 8A, compared to control, treatment of the cells with 100 
µM vanadate for 1 h increased the fluorescence peak intensity from 200 to 1050, 
indicating that in vanadate-treated cells H2O2 generation was enhanced by more than 5 
fold (a and b). Pretreatment of the cells with SOD or formate did not decrease the 
fluorescence intensity (c and d).  However, catalase decreased the intensity almost to the 
control level (e). Similar results were obtained using HE dye for O2C- detection (Figure 
8B). Vanadate increased the fluorescence intensity from 28 to 62, indicating that O2C- 
generation was 2 times higher in vanadate-treated cells than control (a and b). SOD 
decreased the O2C- generation to the control level (c), while neither formate nor catalase 
had a substantial effect (d and e). 
 
In addition, the formation of H2O2 and O2C- induced by vanadate was confirmed 
by confocal microscopy (Figure 9). As shown in Figure 9A, the cells were treated with 
TRITC to visualize unstimulated cells because DCFH-DA itself is colorless (left panel).  
The staining of the cells with TRITC resulted in a red color, allowing the same cells for 
analysis before and after treatment. Additionally, fluorescence can be produced only 
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when DCFH-DA is oxidized to DCF in the presence of H2O2. For this reason the control 
cells could not be observed when DCFH-DA alone was added without vanadate treatment 
(a, right panel). In contrast, treatment with 100 µM vanadate for 1 h results in a green 
fluorescence, which was evidence of vanadate-induced generation of H2O2 (b, right 
panel).  Pretreatment with catalase, a specific scavenger of H2O2, sharply decreased the 
intensity of the green color, confirming that this signal was indeed due to H2O2 
generation (c, right panel). Figure 9B shows the generation of O2C-. The control cells were 
blue due to the addition of HE (a, left panel). In the presence of O2C-, blue HE was 
oxidized to ethidium that fluoresces red. The red color observed in vanadate-treated cells 
indicated that vanadate indeed caused the generation of O2C- (b, right panel). Addition of 
SOD, a scavenger of O2C-, blocked the conversion of HE to ethidium. Therefore, the cells 
remained blue (c, left panel), confirming that O2C-was indeed produced. As O2•- is the 
one-electron reduction product of molecular oxygen, the O2 consumption from cells was 
measured using an oxygraph. O2 consumption was 1600 nmol/106 cells after vanadate 
treatment, whereas it was 1200 nmol/106 cells in controls, i.e., vanadate significantly 
increased O2 consumption by 33% (Figure 10). 
 
Effects of antioxidants on ERK and p38   In the previous sections, we have shown 
that vanadate-stimulated cells are able to generate COH, H2O2 and O2C-. Since both ERK 
and p38 are oxidative stress-sensitive kinases (18), we examined the effects of 
antioxidants on vanadate-induced ERK and p38 activation. As shown in Figure 11, SOD, 
formate and catalase all inhibited activation of both ERK and p38 kinase. The inhibitory 
effect of catalase was more potent than formate and SOD. These results indicate that all 
ROS members were involved in the activation of MAPKs.  
 
Effects of antioxidants on growth regulatory proteins   The effects of antioxidants 
on several growth regulatory enzymes were examined. The results are shown in Figure 
12.  SOD, formate and catalase all exhibited inhibitory effect on vananade-induced p21 
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level with catalase showing a stronger effect.  Neither SOD nor formate had any 
observable effect on vanadate-induced phosphorylation of cdc2. However, catalase 
abolished it. Both SOD and formate partially blocked the degradation of cdc25C. In 
contrast, catalase enhanced the extent of vanadate-induced cdc25C degradation. These 
results show ROS are involved in the regulation of these growth regulatory proteins. 
Specific ROS affect different regulatory proteins and exhibit different potencies. 
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I.5. DISCUSSION 
 
Although vanadate-containing compounds exert potent toxic and carcinogenic 
effects on a wide variety of biological systems, the mechanisms of their actions remain to 
be investigated.  We hypothesize that vanadate-mediated free radical reactions may cause 
a persistent oxidative stress and play a key role in the mechanism of vanadate-induced 
carcinogenesis (24,25).  ROS generated by vanadate-mediated reactions are able to 
damage DNA (26).  Normally, if the cell is injured by external agents, such as vanadate, 
it will respond to such injury by the activation of signal transduction pathways that 
control the modulation of transcription factors and regulation of gene expression as well 
as transiently delaying cell cycle progression to allow the repair of damaged DNA 
(35,57).  Alternatively, if the damage is too severe to be adequately repaired, the cell may 
undergo apoptosis or enter an irreversible senescence-like state (31).  Our recent studies 
have shown that vanadate causes cell growth arrest and apoptosis through H2O2-mediated 
reactions (27,28,58).  The present study shows that vanadate is able to induce cell growth 
arrest and regulate cell growth regulatory enzymes through MAPKs and ROS. 
 
MAPKs can be activated by many stress signals (29,59,60).  These kinases are 
serine/threonine protein kinases that participate in signal transduction of many 
extracellular stimuli, including UV light, bacterial derivatives, and growth factors.  These 
stress-activated kinases have been implicated in the control of several diverse biological 
processes including cell proliferation, development, apoptosis, the response to stress, and 
the production of inflammatory cytokines (61).  Activation of these kinases is marked by 
phosphorylation of serine/threonine amino residues in their protein molecules.  They act 
as signal transducers at the end of kinase cascades that mediate signals from the cell to 
the nucleus.  Activation of these kinases leads to induction of transcription factors that in 
turn regulate gene expression in the nucleus and cell proliferation.  Recent studies have 
shown that MAPKs signaling pathways regulate the eukaryotic cell cycle (61).  It has 
been reported that growth factors can trigger entry into G1 phase of the cell cycle via 
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activation of the Ras signaling pathway (62,63).  MAPKs also have been implicated in 
the regulation of the G2/M transition.  In Xenopus oocytes, activation of MAPKs are 
necessary for progression from meiotic prophase I to metaphase II (64).  After 
fertilization, inactivation of MAPKs is essential for the first G2 to M progression (65).  It 
has been reported that MAPKs play an important role in the G2/M transition in 
mammalian cells (66).  The present study shows that ERK and p38 are involved in 
vanadate-induced cell growth arrest because both PD98059 and SB202190 exhibit 
inhibitory effect with SB202190 being more potent.  Inhibition of ERK or p38 also 
inhibited vanadate-induced expression of p21 and phospho-cdc2 and degradation of 
cdc25C.  It appears that ERK and p38 regulate cell growth arrest at G2/M phase through 
these cell growth regulatory enzymes. 
 
The results obtained from the present study show that ROS generated in vanadate-
stimulated cells are involved in vanadate-induced activation of ERK and p38, which in 
turn regulate cell growth regulatory enzymes leading to cell growth arrest.  Our previous 
studies have shown that vanadate-stimulated cells consumed molecular oxygen that 
generated ROS in the process of vanadate reduction (58).  Using ESR spin trapping, the 
present study detected COH radical generation in vanadate-stimulate cells.  H2O2 serves as 
a precursor for the generation of this radical.  The generation of H2O2 and O2C- were 
detected by flow cytometry and confocal microscopy in combination with specific 
scavengers for these species, catalase and SOD.  From the results obtained in the present 
study and those reported previously (58), it can be concluded that molecular oxygen was 
consumed to generate O2C- radical during the cellular reduction of vanadate; the O2C- 
radical produced H2O2 upon dismutation.  H2O2 produced COH radical via a Fenton-like 
reaction (V(IV) + H2O2 6  COH + OH- + V(V)).  For vanadate-induced phosphorylation of 
p38, O2C- has only minor effect; while both H2O2 and COH are important with H2O2 
exhibiting a stronger effect.  For the phosphorylation of ERK, all of the ROS members 
are involved but none of them exhibits great potency.  For both p21 and phospho-cdc2, 
H2O2 is essential.  For cdc25C, although scavenging of O2C- and COH radical slightly 
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decreased the cdc25C degradation, catalase enhanced cdc25C degradation. Probably the 
effects H2O2 of on cell cycle mainly is through p21 instead of cdc25C. 
 
It may be noted that increasing evidence is accumulating that indicates a vital role 
for ROS in mediating cellular responses by various extracellular stimulators (37).  ROS 
can be generated from many exogenous and endogenous sources in biological systems.  
Exogenous sources of ROS include tobacco smoke, toxic gases, vapors, chemicals, 
pollutants present in ambient air, asbestos, metals, and mineral particles (67).  It is 
possible that these agents may activate MAPKs and alter the status of growth regulatory 
proteins, leading to cell growth arrest. 
 
The results obtained from the present study support the following conclusions: (a) 
vanadate induces cell growth arrest at G2/M phase;  (b) vanadate causes phosphorylation 
of ERK and p38;  (c) vanadate up-regulates p21 and cdc2 and causes degradation of 
cdc25C through both ERK and p38 pathways;  (d) during the cellular reduction of 
vanadate, molecular oxygen is reduced to generate ROS;  (e) ROS are involved in 
vanadate-induced activation of ERK and p38, expression of p21 and cdc2 and 
degradation of cdc25C;  and (f) it may be speculated that other metal carcinogens and 
mineral particles, such as asbestos, chromium, cobalt, nickel, and silica, that are ROS-
promoting agents, may also cause cell growth arrest by a mechanism similar to that of 
vanadate.  
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I.6. FIGURES 
 
 
 
Figure 1   Vanadate-induced cell growth arrest. A549 cells were suspended in F12 K 
nutrient mixture medium containing 10% fetal bovine serum (FBS) in a 100 
mm dish.  After reaching 80-90% confluence, cells were washed with PBS 
three times, and treated with 100 µM vanadate for different times (A). Cells 
were harvested, and DNA content was measured by flow cytometry. Each 
point represents mean ± SD of the percentage of S phase of three independent 
experiments. *, p<0.05 compared to control (one-way ANOVA with 
Scheffe’s test). 
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Figure 1   Vanadate-induced cell growth arrest.  A549 cells were suspended in F12 K 
nutrient mixture medium containing 10% fetal bovine serum (FBS) in a 100 
mm dish.  After reaching 80-90% confluence, cells were washed with PBS 
three times, and treated with different doses for 24 h. Cells were harvested, 
and DNA content was measured by flow cytometry. Each point represents 
mean ± SD of the percentage of S phase of three independent experiments. *, 
p<0.05 compared to control (one-way ANOVA with Scheffe’s test). 
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Figure 2   Effects of vanadate on cell growth regulatory proteins. A549 cells were 
incubated in a 6-well plate until 80-90% confluent. After washing with PBS 
three times, cells were treated with 100 µM vanadate for different times or 
with different concentrations of vanadate for 24 h.  The whole cell lysates 
were collected for Western blotting using specific antibodies to p21, 
cdc25C, and phospho-cdc2Tyr15. Left panel, time dependence. Lane 1, 
control without vanadate; lane 2, 6 h; lane 3, 12 h; lane 4, 24 h; and lane 5, 
48 h. The concentration of vanadate was 100 µM. Right panel, concentration 
dependence. Lane 6, control without vanadate; lane 7, 10 µM; lane 8, 25 
µM; lane 9, 50 µM; lane 10, 100 µM; and lane 11, 200 µM. The incubation 
time was 24 h. Data are from a single preparation representative of three 
independent experiments. 
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Figure 3   Vanadate-induced phosphorylation of ERK and p38. A549 cells were seeded in 
6-well plates. The cells were treated with 100 µM vanadate for 0.5 h to 4 h or 
with different doses of vanadate for 4 h. Western blotting was performed as 
described in Figure 2. Left panel, time dependence.  Lane 1, control without 
vanadate; lane 2, 0.5 h; lane 3, 1 h; lane 4, 2 h; and lane 5, 4 h. The 
concentration of vanadate was 100 µM. Right panel, concentration dependence. 
Lane 6, control without vanadate; lane 7, 10 µM; lane 8, 25 µM; lane 9, 50 µM; 
lane 10, 100 µM; and lane 11, 200 µM. The designations, p and N-p, represent 
the phosphorylated and non-phosphorylated form of the MAPKs. Data are 
from a single preparation representative of three independent experiments. 
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Figure 4   Inhibitory effects of ERK and p38 inhibitors on vanadate-induced activation 
ERK and p38. Western blotting was conducted as described in Figure 2. 
A549 cells were pretreated with PD 98059 and SB 202190 for 0.5 h before 
vanadate treatment (100 µM, 4 h).  Lane 1, control without vanadate; lane 2, 
vanadate; lane 3, vanadate + 50 µM PD; lane 4, vanadate + 100 µM PD; lane 
5, vanadate + 5 µM SB; and lane 6, vanadate + 10 µM SB. The designations, 
p and N-p, represent the phosphorylated and non-phosphorylated form of the 
MAPKs. Data are from a single preparation representative of three 
independent experiments. 
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Figure 5   Inhibitory effects of ERK and p38 inhibitors on vanadate-induced cell growth 
arrest. A549 cells were incubated in a 100 mm dish and pretreated with eithor 
PD 98059 (an ERK inhibitor) or SB 202190 (a p38 kinase inhibitor) for 0.5 h 
prior to vanadate treatment (100 µM) for 24 h. Cell growth arrest was 
analyzed by DNA content using flow cytometry as described in Figure 1. a, 
control; b, vanadate; c, vanadate + 50 µM PD98059; d, vanadate + 100 µM 
PD98059; e, vanadate + 5 µM SB202190; f, vanadate + 10 µM SB202190. 
Each point represents mean ± SD of the percentage of S phase of three 
independent experiments. *, p<0.05 compared to control (one-way ANOVA 
with Scheffe’s test). 
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Figure 6   Effects of ERK and p38 inhibitors on vanadate-regulated cell growth 
regulatory proteins. The cells were pretreated with PD 98059 or SB 202190 
for 0.5 h prior to vanadate treatment (100 µM, 24 h). Proteins p21, 
phospho-cdc2 and cdc25C were analyzed using Western blotting. Lane 1, 
control without vanadate; lane 2, vanadate; lane 3, vanadate + 50 µM PD; 
lane 4, vanadate + 100 µM PD; lane 5, vanadate + 5 µM SB; and lane 6, 
vanadate + 10 µM SB. Data are from a single preparation representative of 
three independent experiments. 
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Figure 7   Hydroxyl radical formation induced by vanadate and the effects of 
antioxidants. 1×106 cells were mixed with 100 mM DMPO and vanadate 
with or without antioxidants, sodium formate or catalase.  ESR spectra 
were recorded for 6 min. a, cells only; b, cells + vanadate; c, cells + 
vanadate + sodium formate; and d, cells + vanadate + catalase. The final 
concentrations were: vanadate, 100 µM; sodium formate, 100 mM; and 
catalase, 2,000 U/ml. Data are from a single preparation representative of 
three independent experiments. 
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Figure 8   Formation of H2O2 and O2•- induced by vanadate and the effects of 
antioxidants detected by flow cytometry. Cells were cultured in a 6-well 
plate. After reaching 80-90% confluence, cells were treated 100 µM 
vanadate for 1 h. For evaluation of antioxidant effects, the cells were 
pretreated with 500 U/ml SOD, 300 µM sodium formate or 5,000 U/ml 
catalase for 0.5 h before treatment with 100 µM vanadate. DCFH-DA was 
added to the cells and incubated for another 15-20 min at 37°C. Then the 
cells were washed with PBS twice and collected for analysis using flow 
cytometry. Panel A represents H2O2 signals. a, control; b, vanadate; c, 
vanadate + SOD; d, vanadate + sodium formate; and e, vanadate + catalase. 
Each point represents mean ± SD of the percentage of S phase of three 
independent experiments. *, # indicate p<0.05 compared to control and 
vanadate treatment, respectively (one-way ANOVA with Scheffe’s test). 
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Figure 8   Formation of H2O2 and O2•- induced by vanadate and the effects of 
antioxidants detected by flow cytometry.  Cells were cultured in a 6-well 
plate.  After reaching 80-90% confluence, cells were treated 100 µM 
vanadate for 1 h. For evaluation of antioxidant effects, the cells were 
pretreated with 500 U/ml SOD, 300 µM sodium formate or 5,000 U/ml 
catalase for 0.5 h before treatment with 100 µM vanadate. HE was added to 
the cells and incubated for another 15-20 min at 37°C. Then the cells were 
washed with PBS twice and collected for analysis using flow cytometry.  
Panel B represents O2•- signals. a, control; b, vanadate; c, vanadate + SOD; 
d, vanadate + sodium formate; and e, vanadate + catalase. Each point 
represents mean ± SD of the percentage of S phase of three independent 
experiments. *, # indicate p<0.05 compared to control and vanadate 
treatment, respectively (one-way ANOVA with Scheffe’s test). 
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Figure 9   Formation of H2O2 and O2•- induced by vanadate and the effects of 
antioxidants detected by confocal microscopy.  The experimental conditions 
were the same as those described in Figure 8. TRITC was added together 
with DCFH-DA. TRITC was used as another dye to observe the presence of 
the cells because DCFH-DA is colorless unless it is oxidized by H2O2. 
Confocal microscopy was used to detect the generation of H2O2. Panel A 
represents the generation of H2O2. a, control; b, vanadate; and c, vanadate + 
catalase. Data are from a single preparation representative of three 
independent experiments. 
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Figure 9   Formation of H2O2 and O2•- induced by vanadate and the effects of 
antioxidants detected by confocal microscopy. The experimental conditions 
were the same as those described in Figure 8. TRITC was added together 
with DCFH-DA. TRITC was used as another dye to observe the presence of 
the cells because DCFH-DA is colorless unless it is oxidized by H2O2. 
Confocal microscopy was used to detect the generation of O2•. Panel B 
represents the generation of O2•-. a, control; b, vanadate; and c, vanadate + 
SOD. Data are from a single preparation representative of three independent 
experiments.  
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Figure 10   Measurement of oxygen consumption. 1×106 cells were prepared for detection 
of oxygen consumption using oxygraph. The final concentration of vanadate 
was 100 µM. Each point represents mean ± SD of the percentage of S phase 
of three independent experiments. * indicates p<0.05 compared to control 
(one-way ANOVA with Scheffe’s test). 
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Figure 11   Effects of antioxidants on vanadate-activated ERK and p38. A549 cells were 
seeded in 6-well plate and pretreated with 500 U/ml SOD, 300 µM sodium 
formate or 5,000 U/ml catalase for 0.5 h before treatment with vanadate (100 
µM).  After 4 h, cells were harvested, and Western blotting was used to 
analyze phosphorylation of ERK and p38. Lane 1, control; lane 2, vanadate; 
lane 3, vanadate + SOD; lane 4, vanadate + sodium formate; and lane 5, 
vanadate + catalase. The designations, p and N-p, represent the 
phosphorylated and non-phosphorylated form of the MAKPs. Data are from 
a single preparation representative of three independent experiments. 
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Figure 12   Effects of antioxidants on vanadate regulated cell growth regulatory proteins. 
A549 cells were incubated in a 6-well plate and pretreated with SOD, sodium 
formate or catalase for 0.5 h before treatment with vanadate (100 µM). After 
24 h, cells were collected for Western blotting using specific antibodies to 
p21, cdc25C, and phospho-cdc2Tyr15. Lane 1, control; lane 2, vanadate; lane 
3, vanadate + SOD; lane 4, vanadate + sodium formate; and lane 5, vanadate 
+ catalase. Data are from a single preparation representative of three 
independent experiments. 
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Figure 13   Schematic representation of possible mechanisms of vanadate (V)-induced 
cell growth arrest and its regulation via generation of H2O2 in A549 cells 
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SECTION II 
 
 
Vanadate-induced S phase Arrest is p53-dependent through Activation 
of p21 in C141 Cells 
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II.1. ABSTRACT 
 
Vanadium is widely used in industry. It is a potent toxic agent and carcinogen. 
The mechanisms involved in its toxicity and carcinogenesis are still unclear. An 
improper cell growth is believed to be involved in cancer development. The present 
study investigated the regulation of p53 on vanadate-induced cell growth arrest using 
both p53 wild type C141 cells and p53 deficient embryo fibroblasts (p53 -/-). On 
vanadate stimulation, C141 cells exhibited a dose- and time-dependent S phase arrest as 
determined by DNA content analysis. In contrast, vanadate was unable to increase the 
percentage of S phase in p53 -/- cells. Luciferase assay showed that vanadate induced 
p53 activation in a dose- and time-dependent manner in p53 wild type C141 cells. 
Addition of pifithrin-α (PFT), a specific inhibitor of p53, reduced the activation of p53 
with a concomitant decrease in growth arrest at S phase. Western blotting analysis 
demonstrated that vanadate caused a dose- and time-dependent increase of p21 level in 
C141 cells. Pretreatment of C141 cells with PFT decreased p21 expression induced by 
vanadate while the p21 expression did not vary in vanadate stimulated p53 -/- cells. The 
results obtained from the present study suggest that vanadate is able to induce S phase 
arrest through p53 and p21-dependent pathway. 
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II.2. INTRODUCTION 
 
Vanadium exists in water, rocks, and soils in low concentrations and in coal and 
oil deposits in relatively high concentrations. Vanadium is widely used in mining, steel 
and steel-alloy making, and in chemical industry. Epidemiological studies have shown a 
correlation between vanadate exposure and the incidence of lung cancer (1,2). Workers 
occupationally exposed to vanadium are at risk as respirable particulates may penetrate 
deeper into the tracheobronchial tree. Vanadium mimics the effect of insulin, and 
stimulates or inhibits several enzymes in vivo and in vitro. Many studies focus on 
mitogenic effects of vanadate, which is mediated by inhibiting the activity of tyrosine 
phosphatase and triggering the autophosphorylation of tyrosine kinase on cell membrane 
receptors (3). However, other mechanisms are plausible. For example, as a pro-oxidant, 
vanadate causes DNA damage, DNA strand breaks, and cell transformation (4,5). 
 
The ability of cells to maintain genomic integrity is vital for cell survival and 
proliferation. Lack of fidelity in DNA replication and maintenance can result in 
deleterious mutations leading to cell death or, in multicellular organisms, cancer (6). 
Minor cell damage is repaired by a temporary pause of cell cycle. If the damage is severe, 
cells will undergo apoptosis and enter into a dormant G0 state. Signal transduction 
pathways play a key role in the regulation of cell cycle progression and stabilization of 
DNA under genotoxic stress. It is known that signal transduction pathways control the 
activation of transcription factors and the regulation of gene expression as well as a 
temporary pause of cell progression to allow the damaged DNA to be repaired. The 
mechanisms involved in the regulations of vanadate on cell cycle control remain 
unknown. 
 
The p53 tumor suppressor is a multifunctional protein that exerts a variety of 
different effects and plays a central role in the regulation of the normal cell cycle. A 
number of different stimuli are known to activate p53 (7). Overexpression of the p53 
59
protein was found to induce cell growth arrest associated with G0/G1 checkpoint (8-10) 
and to induce apoptosis that occurs either through the G0/G1 checkpoint or the S phase 
(11,12), or cell differentiation. Overexpression of the p53 protein has also been suggested 
to be associated with G2/M checkpoint regulation (13,14). Furthermore, p21 (WAF-
1/CIP1) is known to be a transactivation target of p53, and is believed to mediate p53-
induced growth arrest triggered by DNA damage (15,16). Induction of p21 expression 
could serve as an indicator for transactivation by p53, although p21 was also shown to be 
transactivated by p53-independent mechanisms (17). 
 
The purpose of the present study was to identify the possible mechanisms of 
vanadate-induced cell growth arrest. The specific questions to be addressed were: 1) 
Does vanadate induce cell growth arrest? 2) If yes, does p53 play an important role? 3) 
What is the mechanism involved in p53 regulated cell growth arrest? 
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II.3. MATERIALS AND METHODS  
 
Reagents   Sodium metavanadate was from Aldrich (Milwaukee, WI). RNase A, 
DMEM and EMEM medium were from Sigma (St. Louis, MO). Propidium iodide (PI) 
was from Molecular probes (Eugene, OR). Fetal bovine serum (FBS) was purchased from 
Gibco BRL (Life Technologies, Gaithersburg, MD). Pifithrin-α (PFT) was purchased 
from Alexis (San Diego, LA). Antibody to p21 was from Santa Cruz Biotechnology 
(Santa Cruz, CA). Secondary AP linked anti-rabbit IgG was from Cell Signaling 
(Beverly, MA). 
 
Cell culture   The JB6 P+ mouse epidermal cell line, C141 and its stable p53 
luciferase reporter plasmid transfectant, C141 p53 cells were cultured in MEM medium 
containing 5% FBS, 2 mM L-glutamine and 25 µg/ml gentamicin in an incubator at 5% 
CO2 and 37°C. p53-deficient embryo fibroblasts (p53-/-) derived from p53 gene 
knockout mice were incubated in DMEM medium with 10% FBS, 2 mM L-glutamine 
and 25 µg/ml gentamicin at 5% CO2 and 37°C. 
 
Treatments   For the time-course study, the cells were treated with 100 µM 
vanadate for 6, 12, 24, and 48 h. For the dose-response study, the cells were treated with 
10, 25, 50, and 100 µM vanadate for 24 h. For the inhibitory studies of p53, the cells 
were pre-incubated with PFT for 0.5 h prior to the vanadate treatment. 
 
Measurement of cell cycle/DNA content   DNA content in S phase was analyzed 
using flow cytometry according to the methods described previously (18,19). Cells were 
first fixed and permeabilized with 70% ice-cold ethanol for more than 2 h, followed by 
incubation with the freshly prepared staining buffer (0.1% Triton X-100 in PBS, 200 
µg/ml RNase A, and 20 µg/ml PI) for 30 min at room temperature. Cell cycle analysis 
was performed by flow cytometry with at least 10,000 cells for each sample. The DNA 
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content histogram was abstracted and the percentage of cells in S phase was then 
calculated using ModFit LT software. 
 
Luciferase assay for p53 activity   After C141 p53 cells were 80-90% confluent, 
1×104 cells were added into 96-well plate with 100 µl medium in each well. The cells 
were subjected to different treatments according to the experimental design. At various 
time points, the cells were extracted with lysis buffer. The p53 luciferase activity was 
measured using a luminometer (moonlight 3010). The results were expressed as p53 
activity relative to the control. 
 
Western blotting analysis   Whole cell extracts were mixed with Tris-Glycine 
SDS sample buffer and then subjected to Tris-Glycine gel electrophoresis. The resolved 
proteins were transferred to a PVDF membrane. A Western blotting assay was performed 
using antibodies against p21 and secondary anti-rabbit IgG. After reaction with ECF 
substrate, the signal was detected using a Storm Scanner (Molecular Dynamics, 
Sunnyvale, CA). 
 
Statistical analysis   All data were based on at least three independent 
experiments. Cell growth arrest and relative p53 activity data were presented as means ± 
SD and analyzed using one-way ANOVA with the Scheffe’s test. A p value less than 
0.05 was considered statistically significant.  
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II.4 RESULTS 
 
The effects of vanadate in celll cycle in C141 cells and p53 -/- cells   To study 
vanadate-induced cell growth arrest, DNA content was used to measure the percentage of 
different phases. Figure 1A shows that the percentage of S phase increased with the 
increase in vanadate concentration up to 100 µM in C141 cells. The percentage of S 
phase increased from 8% to 30% when vanadate concentration increased from 0 to 100 
µM. Figure 1B shows the results from time-dependent study of vanadate-induced cell 
growth arrest in C141 cells. Treatment of C141 cells with 50 µM vanadate for 6 h did not 
significantly increase the S phase percentage compared to the control. However, the 
difference of S phase percentage increased between the treatment and the control with 
time in C141 cells (Figure 1B), being 12%, 19% and 20% when the cells were treated 
with 50 µM vanadate for 12, 24 and 48 h, respectively. In p53 -/- cells, treatment with 
different concentrations of vanadate for 24 h did not cause any significant increase in S 
phase (Figure 2A). The S phase percentage was 20% and 16% in control cells and 100 
µM vanadate stimulated cells, respectively (Figure 2A). There was no significant 
difference between the treatment of vanadate and the control in p53 -/- cells for 
incubation time up to 48 h (Figure 2B). 
 
Vanadate-induced p53 activation Luciferase assay was used to measure the 
p53 activity in C141 cells. Vanadate treatment caused a dose-dependent increase in p53 
activity (Figure 3A). Upon treatment with 10 µM vanadate for 24 h, the p53 activity 
increased 1.6-fold compared to the control. It was about 5.4-fold when cells were treated 
with 100 µM vanadate. Vanadate also caused a time-dependent activation of p53 as 
shown in Figure 3B. The relative p53 activity increased from 1.4-fold to 5.3-fold when 
vanadate treatment time was increased from 6 h to 48 h. 
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The inhibition of vanadate-induced cell growth arrest   PFT, a specific inhibitor 
of p53, was used to investigate the effect of p53 in vanadate-induced cell growth arrest in 
C141 cells. As shown in Figure 4, 50 µM vanadate significantly increased the percentage 
of S phase. Pretreatment with 10 µM or 20 µM PFT for 0.5 h decreased the percentage of 
S phase to the control level. 
 
The inhibition of vanadate-induced p53 activation   To examine whether PFT is 
able to inhibit vanadate-induced p53 activation, the effect of PFT on p53 activity was 
measured. Figure 5 shows the results of inhibitory effect of PFT on vanadate-activated 
p53 in C141 cells using luciferase assay. Addition of PFT (10 µM) to the stimulated cells 
significantly decreased the relative p53 activity induced by 50 µM vanadate. An increase 
in PFT concentration (20 µM) further attenuated the relative p53 activity. 
 
The effects of vanadate on p21 activation and the role of p53   Western blotting 
was used to detect p21 protein level. Figure 6 shows that C141 cells treated with 50 µM 
vanadate for 6-48 h displayed a time-dependent increase in p21 level (panel A). In 
contrast, p21 decreased when p53 deficient cells were treated with 50 µM vanadate for 6 
h and 12 h (panel B). In addition, vanadate activated p21 in a dose-dependent manner 
when the cells were treated with different concentrations of vanadate for 24 h (Figure 7, 
panel A). In p53 deficient cells, p21 remained the same level as the control when the cells 
were stimulated with 10, 25 and 50 µM vanadate for 24 h (Figure 7, panel B). Expression 
of p21 decreased at 100 µM vanadate treatment. Addition of PFT in stimulated C141 cells 
decreased the p21 level (Figure 8). These results indicate that p53 is required for 
vanadate-induced p21 activation. 
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II.5. DISCUSSION 
 
The present study investigated vanadate-induced cell growth arrest and the role of 
p53. The results obtained from this study demonstrate that: (a) vanadate induced S phase 
arrest in a dose- and time-dependent manner in p53 wild type C141 cells, while no 
significant change was observed in p53 -/- cells; (b) vanadate caused a dose- and time-
dependent increase in p53 activity in C141 cells; (c) PFT, a specific inhibitor of p53, 
blocked the p53 activity with a concomitant decrease in the percentage of S phase 
induced by vanadate; (d) vanadate activated p21 in a dose- and time-dependent manner in 
C141 cells while no change was observed in p53 -/- cells; (e) PFT inhibited p21 
expression in vanadate stimulated C141 cells. 
 
The ability of cells to maintain genomic integrity is vital for cell survival and 
proliferation. The important part in cell growth regulation is the ability of cells to pause 
transiently during the cell cycle in response to agents that cause damage, particularly to 
DNA. Surveillance controls the mechanisms that check and ensure proper completion of 
early events and cellular integrity before initiation of subsequent events in cell cycle 
progression. This process can cause a transient delay that has been suggested to allow the 
cells more time to repair damage before progressing to the next phase (20,21). 
Alternatively, if the damage is too severe to be adequately repaired, the cells may 
undergo apoptosis or enter an irreversible senescence like state (20). In general, the toxic 
effects of vanadium are due to its inhibitory effects on certain enzymatic systems, 
mimicing and regulating growth factor activity and gene expression (22,23). It has been 
reported that sodium vanadate causes G2/M arrest and Rb hypophosphorylation in T98 
glioma cells (24), demonstrating that the G2/M arrest induced by a peroxovanadium 
compound was related to the reduced activity of p34cdc2 and inhibition of Cdc25C (25). A 
2 h exposure of the melanoma cells to sodium vanadate led to a decrease in the activity of 
cyclin D (26). Other studies have indicated that the mitogenesis induced by vanadate in 
CSV3-1 cells was associated with the induction of certain protooncogenes, c-jun and jun 
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B, two major components of the AP-1 transcription factor (27). Our earlier study 
demonstrated that vanadate induced G2/M phase arrest in a dose- and time-dependent 
manner in human epithelial cell line, A549 (28). In the present study, the results showed 
that vanadate caused S phase arrest in mouse epidermal C141 cells. The difference in 
phase arrest induced by vanadate may be cell line specific. 
 
The p53 tumor suppressor is a multifunctional protein that exerts a variety of 
different effects and plays a central role in the regulation of the normal cell cycle (14,29). 
Overexpression of this protein was found to induce growth arrest associated with the 
G0/G1 checkpoint (8-10). At G0/G1 checkpoint, wild type p53 was associated with DNA 
repair activity, and this association prevented the entry into S phase (30,31). At G2 
checkpoint, p53 functions prior to mitosis and takes part in the spindle checkpoint 
associated with mitosis (32). p53 is important for securing the stability and integrity of 
the genome of normal cells and was suggested to be the ‘guardian of the genome’ (33). A 
variety of DNA insults were shown to stabilize the protein, which in turn can either cause 
growth arrest, permit the induction of the DNA repair process, or alternatively, direct 
cells to undergo apoptosis (34). p53 was suggested to be a sensor of damaged DNA, and 
may be involved in the repair process (35). It has been shown that cells containing wild 
type p53 alleles undergo G1 arrest in response to γ-radiation, whereas cells lacking 
functional p53 alleles enter S phase regardless of dose of γ-radiation (36). It has been 
demonstrated that vanadate-mediated generation of reactive oxygen species (ROS) plays 
an important role in various adverse biological effects induced by this metal (37,38). 
Moreover, ROS are believed to be capable of damaging DNA (39). Our earlier study 
showed that vanadate-induced apoptosis was p53 dependent which was mediated by 
H2O2 (40). Our previous study also suggested that ROS are mediators of vanadate-
induced cell growth arrest (28). The results from the present study show that vanadate not 
only induces S phase arrest in C141 cells, but also causes an increase in p53 activity. Our 
study also showed that vanadate caused S phase arrest in p53 +/+ cells derived from 
mouse embryo fibroblasts similarly to that observed in C141 cells (unpublished 
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observations). Due to lack of p53 in p53 -/- cells, vanadate failed to induce growth arrest 
at S phase. Although the mechanism involved in the vanadate-induced cell growth arrest 
remains to be investigated, it is known that ROS generated by vanadate-mediated 
reactions cause DNA damage. This DNA damage may activate signal transduction 
pathways, such as mitogen-activated protein kinase family, leading to an increase in p53 
protein level and its phosphorylation. PFT, an inhibitor of p53, mainly inhibits p53 
function (41). The results obtained from the present study show that addition of 10 µM 
PFT decreased the p53 activity by 42% compared to the stimulated C141 cells (treated 
with 50 µM vanadate for 24 h). The inhibition was stronger when the concentration of 
PFT was increased to 20 µM, being about 60%. More importantly, pretreatment with PFT 
significantly decreased the percentage of S phase induced by vanadate. The percentage of 
S phase in stimulated cells was 27%. It was 8% or 5% after addition of PFT 10 µM or 20 
µM, respectively. There was no significant difference in S phase between the PFT 
pretreated, vanadate-stimulated cells and the control cells (S phase, 8%). 
 
p21 (WAF-1/CIP1) is known to be a transactivation target of p53, and has been 
suggested to mediate p53-indcued growth arrest triggered by DNA damage (42). 
Induction of p21 expression could serve as an indicator for transactivation by p53, 
although p53-independent mechanisms were also observed (14,29). Induction of p21 may 
inhibit cell progression in two ways: (a) by inhibiting a variety of cyclin/cdk complexes 
and (b) by inhibiting DNA synthesis through PCNA binding (43). It is known that cyclin 
A accumulates at the G1/S phase transition and persists through S phase. Cyclin A 
initially associates with cdk2 and then, in late S phase, associates with cdk1. Cyclin A-
associated kinase activity is required for entry into S phase, completion of S phase, and 
entry into M phase (44-46). The p21 protein inhibits the activity of cyclin A/cdk2, which 
in turn phosphorylates the E2F heterodimerization DP1, resulting in an inhibition of E2F 
DNA-binding activity (43). The present study shows that vanadate indeed is able to cause 
a dose- and time-dependent increase in p21 protein level in C141 cells. In contrast, it was 
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unable to activate p21 in p53 -/- cells regardless of dose or time of vanadate treatment. 
Furthermore, addition of PFT significantly decreased p21 protein level activated by 
vanadate, indicating that vanadate-induced activation of p21 is through p53-dependent 
pathway. Our preliminary data also showed that during p21 activation in p53 wild type 
cells vanadate reduced both cyclin A and cdk2 levels. This observation suggests that both 
activated p21 binding and inhibition of cdk2 are involved in vanadate-induced S phase 
arrest. 
 
In conclusion, the results obtained from the present study demonstrate that 
vanadate is capable of inducing S phase arrest in C141 cells that contain wild type p53 
alleles, and this interruption of cell cycle is p53-dependent. Activation of p53 leads to an 
increase in p21 expression, resulting in a pause in growth progression at S phase. Thus, 
vanadate-induced S phase arrest is mediated by p53 through activation of p21. 
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II.6. FIGURES 
 
 
 
 
 
 
Figure 1   Vanadate-induced cell growth arrest in C141 cells. C141 cells were suspended 
in 5% fetal bovine serum (FBS) MEM in a 100 mm dish. After 80-90% 
confluence, cells were washed with PBS three times, and treated with 10, 25, 
50, 100 µM vanadate for 24 h (Panel A). Cells were harvested and DNA 
content was measured by flow cytometry. Each point represents mean ± SD of 
the percentage of S phase of three independent experiments. *, p<0.05 
compared to control (one-way ANOVA with Scheffe’s test). 
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Figure 1   Vanadate-induced cell growth arrest in C141 cells. C141 cells were suspended 
in 5% fetal bovine serum (FBS) MEM in a 100 mm dish. After 80-90% 
confluence, cells were washed with PBS three times, and treated with 100 µM 
vanadate for 6, 12, 24 and 48 h (Panel B). Cells were harvested and DNA 
content was measured by flow cytometry. Each point represents mean ± SD of 
the percentage of S phase of three independent experiments. *, p<0.05 
compared to control (one-way ANOVA with Scheffe’s test). 
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Figure 2   The effect of vanadate on cell growth in p53-deficient embryo fibroblasts (p53 
-/-). p53 -/- cells were suspended in 10% fetal bovine serum (FBS) DMEM in a 
100 mm dish. After 80-90% confluence, cells were washed with PBS three 
times, and treated with 10, 25, 50, 100 µM vanadate for 24 h. Cells were 
harvested and DNA content was measured by flow cytometry. Each point 
represents mean ± SD of the percentage of S phase of three independent 
experiments. *, p<0.05 compared to control (one-way ANOVA with Scheffe’s 
test). 
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Figure 2   The effect of vanadate on cell growth in p53-deficient embryo fibroblasts (p53 
-/-). p53 -/- cells were suspended in 10% fetal bovine serum (FBS) DMEM in a 
100 mm dish. After 80-90% confluence, cells were washed with PBS three 
times, and treated with 50 µM vanadate for 6, 12, 24 and 48 h. Cells were 
harvested and DNA content was measured by flow cytometry. Each point 
represents mean ± SD of the percentage of S phase of three independent 
experiments. *, p<0.05 compared to control (one-way ANOVA with Scheffe’s 
test). 
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Figure 3   Vanadate-induced p53 activation in C141 cells. 1×104 cells were seeded into 
96-well plate with 100 µl medium each well. The cells were treated with 10, 
25, 50, 100 µM vanadate for 24 h. At time points, the cells were extracted 
with lysis buffer. The p53 luciferase activity was measured using a 
luminometer (moonlight 3010). The results were expressed as p53 activity 
relative to the control. Each point represents mean ± SD of the percentage of S 
phase of three independent experiments. *, p<0.05 compared to 10 µM 
vanadate treatment  (one-way ANOVA with Scheffe’s test). 
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Figure 3   Vanadate-induced p53 activation in C141 cells. 1×104 cells were seeded into 
96-well plate with 100 µl medium each well. The cells were treated with 50 
µM vanadate for 6, 12, 24 and 48 h. At time points, the cells were extracted 
with lysis buffer. The p53 luciferase activity was measured using a 
luminometer (moonlight 3010). The results were expressed as p53 activity 
relative to the control. Each point represents mean ± SD of the percentage of S 
phase of three independent experiments. #, p<0.05 compared to 6 h vanadate 
treatment (one-way ANOVA with Scheffe’s test). 
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Figure 4   Inhibitory effects of PFT on vanadate-induced cell growth arrest in C141 cells. 
The cells were incubated in a 100 mm dish and pretreated with 10 and 20 µM 
PFT for 0.5 h before vanadate treatment (50 µM). After 24 h, cells were 
harvested, and DNA content was measured by flow cytometry. Each point 
represents mean ± SD of the percentage of S phase of three independent 
experiments. *, #, p<0.05 compared to control and vanadate treatment, 
respectively (one-way ANOVA with the Scheffe’s test). 
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Figure 5   Inhibitory effects of PFT on vanadate-induced p53 activation in C141 cells. 
1×104 cells were incubated in 96-well plate. The cells were pretreated with 10 
and 20 µM PFT for 0.5 h prior to vanadate stimulation (50 µM). After 24 h, 
the cells were extracted with lysis buffer. The p53 luciferase activity was 
measured using a luminometer (moonlight 3010). The results were expressed 
as p53 activity relative to the control. Each point represents mean ± SD of the 
percentage of S phase of three independent experiments. #, p<0.05 compared 
to vanadate treatment, respectively (one-way ANOVA with Scheffe’s test). 
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Figure 6   Time dependence of vanadate on p21 level in C141 cells and p53 -/- cells. Both 
types of cells were incubated in 6-well plate. The cells were treated with 50 
µM vanadate for a different time. The whole cell lysates were collected for 
Western blotting using specific antibodies to p21. Panel A represented C141 
cells and panel B represented p53 -/- cells. Lane 1, control; lane 2, 6 h; lane 3, 
12 h; lane 4, 24 h; and lane 5, 48 h. Data are from a single preparation 
representative of three indenpend experiments. 
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Figure 7   Dose-response study of vanadate on p21 level in C141 cells and p53 -/- cells. 
The method used is the same as Figure 6. The cells were treated with different 
concentrations of vanadate for 24 h. Panel A represented C141 cells and panel 
B represented p53 -/- cells. Lane 1, control; lane 2, 10 µM vanadate; lane 3, 25 
µM vanadate; lane 4, 50 µM vanadate; and lane 5, 100 µM vanadate. Data are 
from a single preparation representative of three indenpend experiments. 
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Figure 8   The inhibitory effects of PFT on p21 expression in C141 cells. The cells were 
pretreated with 10 µM and 20 µM PFT for 0.5 h prior to vanadate treatment 
(50 µM, 24 h). Western blotting was used to examine the p21 level. Lane 1, 
control; lane 2, 50 µM vanadate for 24 h; lane 3, 50 µM vanadate + 10 µM 
PFT for 24 h; and lane 4, 50 µM vanadate + 20 µM PFT for 24 h. Data are 
from a single preparation representative of three indenpend experiments. 
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SECTION III 
 
 
Vanadate Induces G2/M Phase Arrest in p53 Deficient Mouse 
Embryo Fibroblasts 
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III.1. ABSTRACT 
 
 Vanadium compounds exert potent toxic and carcinogenic effects on a wide 
variety of biological systems. The mechanisms involved in their toxicity and 
carcinogenesis remain to be investigated. Cell growth arrest and its regulation are 
important mechanisms in maintaining genomic stability and integrity in response to 
environmental stress. The p53 tumor suppressor plays a central role in the regulation of 
the normal cell cycle. In order to investigate the role of p53 in vanadate-induced cell 
growth arrest and its regulation, two cell lines, normal mouse embryo fibroblasts (p53 
+/+) and p53 deficient mouse embryo fibroblasts (p53 -/-), were used in the present 
study. Flow cytometry was used to analyze cell growth arrest at G0/G1, S or G2/M phase. 
Western blotting analysis was performed to determine several cell growth regulatory 
proteins. The results show that in p53 -/- cells vanadate induced G2/M phase arrest in a 
dose- and time-dependent manner without alteration of S phase. In p53 +/+ cells, 
vanadate treatment increased S phase with no significant change at G2/M phase. 
Furthermore, Western blotting results show that in p53 -/- cells vanadate caused cdc25C 
degradation and activation of phospho-cdc2 without alteration of p21 level. In p53 +/+ 
cells, vanadate increased expression of p21 and degraded cdc25A instead of cdc25C 
without any effect on cdc2. These results demonstrate that vanadate induced G2/M phase 
arrest in p53 deficient mouse embryo fibroblasts, and caused S phase arrest in p53 wild 
type mouse embryo fibroblasts. 
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III.2. INTRODUCTION 
 
 The ability of cells to maintain genomic integrity is vital for cell survival and 
proliferation. Lack of fidelity in DNA replication and maintenance results in deleterious 
mutations leading to cell death or cancer (1). Surveillance systems exist to ensure proper 
completion of cell cycle progression. The transition stages of cell cycle are regulated by 
various protein kinases or their complexes composed of cyclin and cyclin-dependent 
kinases (2). Checkpoints can induce a transient delay to provide the cells more time to 
repair the damage before progression to the next phase of cell cycle (1). 
 
 The p53 tumor suppressor gene is a transcription factor that plays an important 
role in signal transduction in response to DNA damage (3). p53 mediates various cellular 
functions such as DNA repair, maintenance of genetic stability, and induction of cell 
cycle arrest or apoptosis. It has been reported that both p53-dependent and p53-
independent pathways are involved in the cell cycle regulation (4). Generally, p53 is 
considered an important factor in the regulation of cell cycle. p53-dependent cell growth 
arrest in G1 phase is an important component of the cellular response to stress. Recent 
study indicates that p53 controls the entry into mitosis when cells enter G2 phase with 
damaged DNA or when they are arrested in S phase due to depletion of the substrates 
required for DNA synthesis (5). 
 
 Vanadium is widely distributed in the environment and is a trace metal in 
biological systems (6-8). Vanadate compounds are potent toxins and carcinogens (9-12). 
Epidemiological studies have shown a correlation between vanadium exposure and the 
incidence of lung cancer in humans (13,14). Vanadate compounds were reported to 
modify DNA synthesis and repair (15-18). Vanadate was also shown to induce forward 
mutation and DNA-protein crosslinks in cultured mammalian cells (19). It also has been 
reported that vanadate exhibits mitogenic effects by inhibiting the activity of tyrosine 
phosphatase and triggering the autophosphorylation of tyrosine kinase on cell membrane 
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receptors (20). Vanadate regulates growth-factor-mediated signal transduction pathways, 
promotes cell transformation, exerts inhibitory effects on certain enzymatic systems, and 
decreases cell adhesion (21-23). While the mechanisms of vanadate-induced toxicity and 
carcinogenicity remain to be investigated, reactive oxygen species (ROS) are considered 
to play an important role. Through ROS, vanadate compounds cause direct DNA damage, 
such as strand breaks and hydroxylation of dG residues, activate certain nuclear 
transcription factors, such as AP-1 (24), NF-κB (25), p53 (26) and nuclear factor of 
activated T cells (NFAT) (27), and induce apoptosis (26,28). Our previous studies have 
found that vanadate-induced cell growth arrest is cell type specific. Vanadate caused 
G2/M phase arrest in human epithelial A549 cell line, and this arrest is mediated by ROS 
(29). 
 
 The purpose of present study was to investigate the role of p53 in vanadate-
induced cell growth arrest and to attempt to answer the following questions: 1), Does 
vanadate induce cell growth arrest in mouse embryo fibroblasts? 2), Does p53 mediate 
the vanadate-induced cell growth arrest? 3), What checkpoints are involved in the cell 
cycle regulation? 
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III.3. MATERIALS AND METHODS 
 
 Reagents   Sodium metavanadate was from Aldrich (Milwaukee, WI). RNase A 
and DMEM medium were purchased from Sigma (St. Louis, MO). Propidium iodide (PI) 
was from Molecular Probes (Eugene, OR). Fetal bovine serum (FBS) was from Gibco 
BRL (Life Technologies, Gaithersburg, MD). Antibodies against p21, cdc25A, cdc25C 
were from Santa Cruz Biotechnology (Santa Cruz, CA). Phospho-cdc2tyr15 and secondary 
AP linked anti-rabbit IgG were from Cell Signaling (Beverly, MA). 
 
 Cell culture   Normal mouse embryo fibroblasts (p53 +/+) and p53-deficient 
mouse embryo fibroblasts (p53 -/-) were incubated in DMEM medium with 10% FBS, 2 
mM L-glutamine, and 1000 U/ml penicillin-streptomycin in an incubator at 5% CO2 and 
37°C. 
 
 Treatments   For the time-course study, cells were treated with 50 µM vanadate 
for 6, 12, 24, and 48 h. For the dose-response study, cells were treated with 10, 25, 50, 
and 100 µM vanadate for 24 h.  
 
 Measurement of cell cycle/DNA content   DNA content in G2/M phase was 
analyzed using flow cytometry according to the methods described previously (30,31). 
Cells were fixed and permeabilized with 70% ethanol for more than 2 h, and then 
incubated with the freshly prepared staining buffer (0.1% Triton X-100, 200 µg/ml 
RNase A, and 20 µg/ml PI) for 30 min at room temperature. Cell cycle analysis was 
performed by flow cytometry with at least 10,000 cells for each sample. The DNA 
content histogram was abstracted and the percentage of cells in G2/M phase was 
calculated using ModFit LT software. 
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 Western blotting analysis   Whole cell extracts were mixed with Tris-Glycine 
SDS sample buffer and the proteins were separated by Tris-Glycine gel electrophoresis. 
The resolved proteins were transferred to a PVDF membrane. Western blotting was 
performed using antibodies to p21, cdc25A, cdc25C, phospho-cdc2tyr15 and secondary 
anti-rabbit IgG. After reaction with ECF substrate, the signal was detected using a Storm 
Scanner (Molecular Dynamics, Sunnyvale, CA). 
 
 Statistical analysis   All data were based on at least three independent 
experiments. Cell growth arrest data were presented as means ± SD and analyzed using 
one-way ANOVA with the Scheffe=s test. A p value less than 0.05 was considered 
statistically significant.  
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III.4. RESULTS 
 
 Effects of vanadate in celll cycle   To study vanadate-induced cell growth arrest, 
flow cytometry was used to measure the percentage of cells in each phase. Figure 1a 
shows a typical histogram of cell cycle. The first peak represents the G0/G1, the second 
one G2/M, and that between these two peaks is S phase. As shown in Figure 1A, 
treatment of p53 -/- cells with 50 µM vanadate for 24 h increased the percentage of the 
cells at G2/M phase, being 42% vs 18% in control. Interestingly, treatment of p53 +/+ 
cells with vanadate did not change the percentage of cells at G2/M phase. However, 
vanadate stimulation caused an increase in S phase.  
 
 Figure 1B shows the time dependence of vanadate-induced cell growth arrest at 
G2/M phase. As shown in this figure, in p53 -/- cells, the percentage of cells at G2/M 
phase increased from 18% at beginning of treatment to 42% when the cells were treated 
with vanadate for 24 h. In contrast, in p53 +/+ cells the percentage of cells at G2/M phase 
did not change with vanadate exposure.  
 
 Figure 1C shows the dose-dependence of vanadate-induced cell growth arrest at 
G2/M phase. As shown in this figure, in p53 -/- cells there was a dose-dependent increase 
at G2/M phase. The highest percentage of cells at G2/M phase was 42% when the cells 
were treated with 50 µM vanadate for 24 h. In p53 +/+ cells, the percentage of cells at 
G2/M phase was essentially unchanged regardless of the concentrations of vanadate. 
 
 Effects of vanadate on p21   One of the important cell growth regulatory proteins 
is p21. The protein level of this enzyme was measured by Western blotting. Figure 2, 
panel A shows that treatment of p53 -/- cells with 50 µM vanadate for 6 h and 12 h 
decreased p21 level. No significant change was observed at 24 h or 48 h of vanadate 
treatment. The treatment of p53 +/+ cells with 50 µM vanadate for 6 h and 12 h caused a 
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weak induction of p21. A marginal increase of p21 was observed at 24 h and 48h of 50 
µM vanadate treatment. Panel B shows dose-dependence of vanadate treatment. In p53 -
/- cells, at 24 h incubation, vanadate did not cause p21 induction regardless vanadate 
concentrations. In p53 +/+ cells, 10 µM vanadate caused an observable p21 induction. An 
increase in vanadate concentrations did not enhance the p21 induction. 
 
 Effects of vanadate on cdc25C   To investigate involvement of cell cycle 
regulatory protein, expression of cdc25C was examined in both p53 -/- cells and p53 +/+ 
cells. Figure 3 shows that in p53 -/- cells vanadate caused a time- and dose-dependent 
degradation of cdc25C (panels A and B). The cdc25C signal almost disappeared in cells 
treated with 50 µM vanadate for 24 h and 48 h (panel A, lanes 4 and 5), and 100 µM 
vanadate for 24 h (panel B, lanes 4 and 5). However, in p53 +/+ cells the cdc25C did not 
exhibit any significant change regardless of incubation times (panel A) or treatment 
concentrations (panel B). 
 
 Effects of vanadate on cdc25A   Tyrosine phosphotase cdc25A was detected using 
Western blotting (Figure 4). In p53 -/- cells the expression of cdc25A did not change 
regardless of vanadate stimulation times (panel A) or doses (panel B). In p53 +/+ cells, 
50 µM vanadate treatment caused maximal degradation of cdc25A at 48 h (panel A, lane 
5). The degradation of this protein was also observed when the cells were treated with 50 
µM vanadate for 24 h (panel B, lane 4). 
 
 Effects of vanadate on cdc2   Another important kinase in the control of cell cycle 
progression from G2 to M phase is cdc2. Western blotting was also used to study the 
effects of vanadate on this protein. Figure 5, panel A shows that in p53 -/- cells treatment 
with 50 µM vanadate activated phospho-cdc2 at 6 h to 24 h. In contrast, in p53 +/+ cells, 
vanadate caused a decrease in cdc2 at 12 h (panel A, lane 3) and a complete inhibition at 
24 h (panel A, lane 4) when the cells were treated with 50 µM vanadate. In p53 -/- cells, a 
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dose-independent increase in cdc2 was observed after 10 µM to 50 µM vanadate 
treatment. Treatment of p53 +/+ cells with vanadate at 25 µM and 50 µM decreased cdc2 
(panel B, lanes 3 and 4). 
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III.5. DISCUSSION 
 
 Damage to growing cells causes a temporary pause in G1/S, or G2/M phase until 
the damage is repaired. When damage is severe, cells may either undergo apoptosis or 
enter a dormant G0 state (32-34). 
 
 Similar to apoptosis or programmed cell death, cell growth arrest is a cell self 
defense system to prevent genetically damaged cells from passing to the next generation. 
Investigation on the cell growth arrest upon exposure of the cells to a carcinogen is an 
important part for the overall understanding of the mechanism of chemical-induced 
carcinogenesis. Vanadate-containing compounds exert potent toxic and carcinogenic 
effects on a wide variety of biological systems, although the mechanisms involved are 
still unclear. Using human epithelial cell line, A549 cells, our previous study has shown 
that vanadate is able to induce cell growth arrest at G2/M phase. This arrest is mediated 
by vanadate-induced ROS reactions. Mitogen-activated protein kinases (MAPKs) also 
play a critical role in the regulation of vanadate-induced cell growth arrest at G2/M phase 
(29). The results from our laboratory demonstrated that vanadate caused S phase arrest in 
C141 cells. The regulation of the S phase arrest is both p53 and p21-dependent 
(unpublished observations). The present study shows that vanadate induces G2/M phase 
arrest in a dose- and time-dependent manner in p53 -/- mouse embryo fibroblasts. In 
contrast, vanadate had no effect on G2/M phase but caused S phase arrest in p53 +/+ 
cells. It may be noted that hematopoietic cells that either lack p53 gene expression or 
overexpress a mutant form of the p53 gene exhibited a G2 arrest after gamma-irradiation, 
confirming that the G2 arrest can be p53 independent (35). A recent study from our group 
demonstrated that induction of GADD45α in arsenite-induced G2/M phase arrest was 
p53-independent. Moreover, the activation of GADD45α by arsenite was higher in p53 -
/- cells than in p53 +/+ cells. All these data indicate that the G2/M phase arrest can be p53 
independent (36). However, some studies have shown the importance of p53 in G2/M 
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arrest. For example, p53 is required for the G2 arrest in response to ionizing radiation in 
IMR-90 normal lung fibroblasts (37). Other studies have indicated that inactivation of 
p53 by large T antigen is responsible for abrogating the G2 checkpoint (38-40). Caffeine 
abrogated G2 arrest in response to ionizing radiation in mouse embryo fibroblasts derived 
from p53-knockout mice and in rat embryo fibroblasts expressing the dominant negative 
V143A mutant of human p53 (41). 
 
 Checkpoints are control mechanisms that ensure the proper timing of cell cycle 
events by enforcing the dependency of later events on the completion of early events. 
Movement of cells from G2/M is regulated by both cyclin A and cdc2/cyclin B. The 
activity of cdc2/cyclin B kinases peaks in late G2 and remains high until their degradation 
(42). Earlier studies have shown that G2/M arrest induced by a peroxovanadium 
compound was related to the reduced activity of p34cdc2 and inhibition of cdc25C (43). 
Our previous study also showed that sodium vanadate-induced G2/M phase arrest was 
regulated by both phospho-cdc2tyr15 and cdc25C (29). γ-irradiation resulted in an 
accumulation of Thr14/Tyr15 phosphorylated cdc2, leading to inhibition of cdc2/cyclin B 
activity (2,44). It has been reported that sodium vanadate caused G2/M arrest and Rb 
hypophosphorylation in T98 glioma cells (45). The present study shows that vanadate 
activated phospho-cdc2 in p53 -/- cells.  But it decreased phospho-cdc2 in p53 +/+ cells. 
 
 There are two pathways associated with activation of cdc2/cyclin B complex: (a) 
cdc25C phosphatase associates with cdc2/cyclin B complex and activates it by 
dephosphorylated Thr14/Tyr15 (46), and this association between cdc25C and 
cdc2/cyclin B complex may be blocked through the actions of the Chk1 and Chk2 kinases 
which phosphorylate cdc25C on serine 216 (1). This phosphorylation is necessary for 
cdc25C to bind to 14-3-3 proteins and its apparent sequestration from the cdc2/cyclin B 
complex (47-49). (b) Transcriptional activation of p21WAF1/CIP1 makes this protein bind to 
and inactivates cdc2/cyclin B complex that is required for the cell cycle progression (50-
52). Our results show: (a) Vanadate was able to cause degradation of cdc25C in p53 -/- 
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cells. The degradation of this protein leads to failure in dephosphorylation of cdc2 at 
Tyr15, resulting in inactivation of the cdc2/cyclin B complex. Instead of cdc25C, 
cdc25A, a checkpoint phosphotase for S phase, was degraded in vanadate-stimulated p53 
+/+ cells. (b) Vanadate had no effect on p21 level in p53 -/- cells regardless of treatment 
time and dose due to the deficiency of p53, although the activation of p21 might be p53-
independent. In contrast, vanadate slightly increased the level of p21 protein in p53 +/+ 
cells. The explanation is that vanadate increased the percentage of S phase instead of 
change in G2/M phase in p53 +/+ cells. The S phase arrest depended on p53 that was p21-
dependent. It has been reported that cdc2 is likely to be inhibited by Thr14/Tyr15 
phosphorylation which is catalyzed by cdc25, whereas cdk2, which is an important 
checkpoint of S phase, is likely to be inhibited by association with p21 after UN radiation 
(53). Probably, a similar mechanism exists in the vandate-induced S phase arrest in 
mouse embryo fibroblasts, p53 -/- cells and p53 +/+ cells. The results from our previous 
study have also demonstrated that vanadate indeed increased p53 protein level, resulting 
in activation of p21. Both p53 and p21 levels decreased after pretreated with pifithrin-α, 
a specific inhibitor of p53 in JB6 cells (29). 
 
 In summary, in p53 -/- cells, vanadate is able to induce G2/M phase arrest. It 
causes degradation of cdc25C and activation of cdc2. While it does not alter the 
expression of p21 and cdc25A. In p53 +/+ cells, vanadate does not change the percentage 
of cells at G2/M phase, but increases the percentage of the cells at S phase. Vanadate has 
no effect on cdc2 or cdc25C, but it increases p21 level and degrades cdc25A. 
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III.6. FIGURES 
 
 
 
 
 
Figure 1   Effects of vanadate on cell growth arrest in both p53 -/- and p53 +/+ cells. p53 
+/+ and p53 -/- cells are p53 wild type and p53 deficient mouse embryo 
fibroblasts, respectively. These two type of cells were incubated in DMEM 
medium with 5 % FBS in 100 mm dish. After 80-90% confluent, the cells were 
treated with vanadate for different times and different doses. The cells were 
harvested, and flow cytometry was used to measure DNA content. Panel A 
shows the profile of cell cycle. a, control without vanadate treatment; b, 
treatment of the cells with 50 µM vanadate for 24 h. 
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Figure 1 Effects of vanadate on cell growth arrest in both p53 -/- and p53 +/+ cells. p53 
+/+ and p53 -/- cells are p53 wild type and p53 deficient mouse embryo 
fibroblasts, respectively. These two type of cells were incubated in DMEM 
medium with 5 % FBS in 100 mm dish. After 80-90% confluent, the cells 
were treated with vanadate for different times and different doses. The cells 
were harvested, and flow cytometry was used to measure DNA content. Panel 
B represents the time-course of vanadate-induced cell growth arrest at G2/M 
phase. Each point represents mean ± SD of three independent experiments.*, 
p<0.05 compared to control (one-way ANOVA with the Scheffe=s test). 
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Figure 1   Effects of vanadate on cell growth arrest in both p53 -/- and p53 +/+ cells. p53 
+/+ and p53 -/- cells are p53 wild type and p53 deficient mouse embryo 
fibroblasts, respectively. These two type of cells were incubated in DMEM 
medium with 5 % FBS in 100 mm dish. After 80-90% confluent, the cells were 
treated with vanadate for different times and different doses. The cells were 
harvested, and flow cytometry was used to measure DNA content. Panel C 
represents dose-response of vanadate on cell cycle arrest at 24 h. Each point 
represents mean ± SD of three independent experiments. *, p<0.05 compared 
to control (one-way ANOVA with the Scheffe=s test). 
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Figure 2 Effects of vanadate on cell growth inhibitory protein p21 in both p53 -/- 
and p53 +/+ cells. The two cells were seeded in 6-well plate. Then the 
cells were treated with 50 µM vanadate for 6 h, 12 h, 24 h, and 48 h. The 
whole-cell lysates were collected, and Western blotting was performed 
to detect the expression of p21. Lane 1, control; lane 2, 6 h; lane 3, 12 h; 
lane 4, 24 h; and lane 5, 48 h. The concentration of vanadate used was 
50 µM. Data are from a single preparation representative of three 
indenpend experiments. 
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Figure 2 Effects of vanadate on cell growth inhibitory protein p21 in both p53 -/- 
and p53 +/+ cells. The two cells were seeded in 6-well plate. Then the 
cells were treated with 10 µM, 25 µM, 50 µM, and 100 µM vanadate for 
24 h. The whole-cell lysates were collected, and Western blotting was 
performed to detect the expression of p21. Lane 1, control; lane 2, 10 
µM; lane 3, 25 µM; lane 4, 50 µM; and lane 5, 100 µM vanadate. The 
incubation time was 24 h. Data are from a single preparation 
representative of three indenpend experiments. 
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Figure 3 Effects of vanadate on cell growth regulatory protein cdc25C. The 
method used is described in detail in the legend to Figure 2. The 
Western blotting was used to measure cdc25C level. Lane 1, control; 
lane 2, 6 h; lane 3, 12 h; lane 4, 24 h; and lane 5, 48 h. The concentration 
of vanadate used was 50 µM. Data are from a single preparation 
representative of three indenpend experiments. 
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Figure 3 Effects of vanadate on cell growth regulatory protein cdc25C. The 
method used is described in detail in the legend to Figure 2. The 
Western blotting was used to measure cdc25C level. Lane 1, control; 
lane 2, 10 µM; lane 3, 25 µM; lane 4, 50 µM; and lane 5, 100 µM 
vanadate. The incubation time was 24 h. Data are from a single 
preparation representative of three indenpend experiments. 
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Figure 4 Effects of vanadate on cell growth regulatory protein cdc25A. As 
described in detail in the legend to Figure 2, Western blotting was 
conducted to determine the expression of cdc25A. Lane 1, control; lane 
2, 6 h; lane 3, 12 h; lane 4, 24 h; and lane 5, 48 h. The concentration of 
vanadate used was 50 µM. Data are from a single preparation 
representative of three indenpend experiments. 
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Figure 4 Effects of vanadate on cell growth regulatory protein cdc25A. As 
described in detail in the legend to Figure 2, Western blotting was 
conducted to determine the expression of cdc25A. Lane 1, control; lane 
2, 10 µM; lane 3, 25 µM; lane 4, 50 µM; and lane 5, 100 µM vanadate. 
The incubation time was 24 h. Data are from a single preparation 
representative of three experiments. 
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Figure 5 Effects of vanadate on cell cycle checkpoint cdc2. The experimental 
conditions were the same as these described in the legend to Figure 2. 
The whole-cell lysates were used to perform Western blotting. Lane 1, 
control; lane 2, 6 h; lane 3, 12 h; and lane 4, 24 h. The concentration of 
vanadate used was 50 µM. Data are from a single preparation 
representative of three experiments. 
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Figure 5 Effects of vanadate on cell cycle checkpoint cdc2. The experimental 
conditions were the same as these described in the legend to Figure 2. 
The whole-cell lysates were used to perform Western blotting. Lane 1, 
control; lane 2, 10 µM; lane 3, 25 µM; and lane 4, 50 µM vanadate. The 
incubation time was 24 h. Data are from a single preparation 
representative of three experiments. 
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SECTION IV 
 
 
MAPKs Mediate S Phase Arrest Induced by Vanadate through a p53 
Dependent Pathway in Mouse Epidermal C141 Cells 
114
IV.1. ABSTRACT 
 
Mitogen-activated protein kinases (MAPKs) play an important role in mediation 
of signal transduction pathway in cellular response to genotoxic stress. Cell growth arrest 
is considered as an early stage in response to the genotoxic stress. p53 is well known as a 
tumor suppression gene involved in both cell growth arrest and apoptosis. The present 
study investigated the involvement of MAPKs in vanadate-induced cell growth arrest and 
the relationship of p53. DNA content analysis showed that vanadate induced S phase 
arrest is time- and dose-dependent in p53 wild type C141 cells but not in p53 deficient 
C141 cells. Western blotting results indicated that vanadate caused an inactivation of p-
cdk2 at Thr160, which is an important kinase for the progression of S phase, and an 
increase in expression of p21, which is a key for S phase arrest. In p53 deficient cells, 
vanadate did not induce any observable change in p21 or p-cdk2 level. In addition, 
vanadate up-regulated phospho-p38 and ERK, two members of MAP kinases. At the 
same time, vanadate increased the p53 activity as measured by luciferase assay. Addition 
of PD98059 and SB202190, inhibitors of ERK and p38, respectively, decreased vanadate-
induced S phase arrest, reduced p21 level, restored activation of p-cdk2, and decreased 
p53 activity. The study demonstrated that vanadate-induced S phase arrest is mediated by 
both ERK and p38 in p53-dependent pathway. 
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IV.2.   INTROUCTION 
 
Exposure of cells to genotoxic agents evokes a series of events leading to the 
activation of a wide spectrum of genes with diverse functions. A number of transcription 
factors as well as various gene products are involved in response to mitogenic 
stimulation, illustrating that signal transduction pathways are involved in mediating the 
cellular response to stress and proliferative signals (19). 
 
The mitogen-activated protein kinases (MAPKs) pathway has a central role in 
cellular signaling (20). MAPKs include three major components which are extracellular 
signal-regulated kinases (ERK), stress activated protein kinases (SAPK)/c-Jun N-terminal 
kinases (JNK), and p38/RK/CSBP kinases. These kinases play a key role in the activation 
of transcription factors and other regulatory proteins involved in activating gene 
expression (8). A common feature of MAPKs is their activation through phosphorylation 
of threonine and tyrosine residues in a homogenous kinase subdomain VIII (8). Upon 
activation, MAPKs translocate into the nucleus where they phosphorylate transcription 
factors and thereby alter gene transcription patterns (6, 26). Over-activation of these 
protein kinases can lead to uncontrolled cell growth and tumorigenesis (28).  
 
ERK is one of the most characterized signaling pathways that connect different 
types of membrane receptors to the nucleus after mitogenic stimulation (12, 44) or 
differentiation (32). The activation of ERK involves the activation of low-molecular-
weight GTP-bonding proteins (Ras) at the plasma membrane and the sequential activation 
of a series of protein kinases: a MAPK kinase kinase (Raf-1) is activated and then by 
phosphorylation it activates a MAPK kinase (MEK1/2), which in turns phosphorylates 
ERK on threonine and tyrosine residues, leading to ERK activation (53). ERK is able to 
phosphorylate cytoplasmic and nuclear targets (16, 29). This pathway has been found to 
play a critical role in the control of cell proliferation via growth factor receptors and 
integrins (22). p38, another important member of MAPKs, is involved in inflammation, 
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cell differentiation, cell cycle regulation, and cell death (38). p38 pathway shares many 
similarities with other MAP kinase cascades. Similar to other MAPKs, p38 is activated by 
dual kinase, the MAP kinase kinase (MKK). Besides the same pathway as the ERK in 
Ras/Raf/MEK/MAPK, the Rho family, Rac and cdc42 were also identified as potential 
regulators of the p38 pathway (4, 40, 57). 
 
 The p53 tumor suppressor protein appears to serve numerous functions during the 
cellular response to genotoxic stress, some of which act as a transcription factor to 
activate gene expression (20). p53 is considered an important mediator in the cell cycle. 
Various kinases including double-stranded DNA-activated protein kinase (DNA-PK), 
cyclin A and cyclin B-associated kinase cdc2, ERK and JNK have been implicated in p53 
phosphorylation that in turn participates in regulation of p53 activity (2, 33, 34). 
 
 Vanadate is an essential trace element. It is widely found in occupational and 
environmental systems. Epidemiological studies have shown a correlation between 
vanadium exposure and the incidence of lung cancer in humans (21, 37, 42). Vanadium 
compounds were reported to modify DNA synthesis and repair (9, 21, 42), induced 
mutations and DNA-protein crosslinks (9, 18, 30, 49, 59). Vanadate is able to induce 
G2/M phase arrest through MAPKs pathway mediated by reactive oxygen species (ROS) 
in A549 cells. A study from our group also indicated that vanadate caused p53 dependent 
S phase arrest in mouse epidermal C141 cells. 
 
 The purposes of the present study are: 1) to examine of effects of vanadate on 
MAPKs; 2) to understand the relationship between MAPKs and cell growth arrest 
induced by vanadate; and 3) to investigate the role of p53 in vanadate-induced cell growth 
arrest. 
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IV.3. MATERIALS AND METHODS 
 
Reagents   Sodium metavanadate was purchased from Aldrich (Milwaukee, WI). 
Dulbecco’s modified eagle medium (DMEM) and Eagle’s minimal essential medium 
(MEM) were from Sigma (St. Louis, MO). Fetal bovine serum (FBS) was from Gibco 
BRL (Life Technologies, Gaithersburg, MD). Antibody against p21 was from Santa Cruz 
Biotechnology (Santa Cruz, CA). Antibodies against phospho-cdk2, p38 and ERK, and 
secondary AP linked anti-rabbit IgG were from Cell Signaling (Beverly, MA). 
 
Cell culture   The JB6 P+ mouse epidermal cell line, C141 cells were stably 
transfected with p53 luciferase reporter, and cultured in MEM medium containing 5% 
FBS, 2 mM L-glutamine and 1000 U/ml penicillin-streptomycin in an incubator at 5% 
CO2 and 37°C.  
 
Determination of lactate dehydrogenase leakage   Activity of lactate 
dehydrogenase  (LDH) leakage was measured using an FARA Chemical Analyzer with 
the test kit (Roche, Gaithersburg, MD).  The total LDH activity was measured after cells 
were disrupted using ultrasonication.  LDH leakage (%) was calculated as LDH activity 
in medium/total LDH activity x 100.  
 
Measurement of cell cycle/DNA content   DNA content in G1, S and G2/M phase 
was analyzed using flow cytometry (39, 45). Cells were fixed and permeabilized with 
70% ethanol for more than 2 h, and then incubated with the freshly prepared staining 
buffer (0.1% Triton X-100, 200 µg/ml RNase A, and 20 µg/ml PI) for 30 min at room 
temperature. For flow cytometric analysis, at least 10,000 cells were used in each sample. 
The DNA content histogram was abstracted and the percentage of cells in S phase was 
calculated using ModFit LT software. 
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Western blotting analysis   Whole cell extracts were mixed with Tris-Glycine 
SDS sample buffer and then performed Tris-Glycine gel electrophoresis. The resolved 
proteins were transferred to PVDF membrane. Western blotting was performed using 
antibodies against p21, phospho-cdk2 at Thr160, ERK and p38, and secondary anti-rabbit 
IgG. After reaction with ECF substrate, the signal was detected using a Storm Scanner 
(Molecular Dynamics, Sunnyvale, CA). 
 
Luciferase assay for p53 activity    After C141 cells were 80-90% confluent, 
1×104 cells were placed into a 96-well plate with 100 µl MEM medium in each well. The 
cells were treated by vanadate with different times and doses. At various time points, the 
cells were extracted with lysis buffer. The p53 luciferase activity was measured using a 
luminometer (moonlight 3010). The results were expressed as p53 activity relative to the 
control. 
 
Statistical analysis   All data were based on at least three independent 
experiments. Relative p53 activity was presented as means ± SD and analyzed using one-
way ANOVA with the Scheffe’s test. A p value less than 0.05 was considered statistically 
significant. 
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IV.4. RESULTS 
 
Toxicity of vanadate   The toxicity of vanadate in C141 cells was examined by 
measuring LDH leakage.  Figure 1A shows that at concentrations up to 100 µm for an 
incubation time of 24 h vanadate did not  exhibit any significant toxicity.  No significan 
toxicity was observed for 50 µM vanadate incubation times up to 48 h (Figure 1B).  
These results indicate that at the concentrations used in the present study, vanadate did 
not cause any significant toxic effect.  
 
Effects of vanadate on cell cycle   To study the effects of vanadate on cell growth 
arrest in C141 cells, flow cytometry was performed to analyze DNA content. Figure 2 
shows that vanadate caused time-dependent increase at S phase in C141 cells. The 
percentage of cells at S phase was 14.40% in 50 µM vanadate-treated C141 cells for 6 h 
(b) instead of 8.02% in control without stimulation (a). The percentage of cells at S phase 
attained the highest (30.03%) at 24 h treatment (d). The results from dose-dependent 
study are shown in Figure 3. In this study, C141 cells were treated with 10, 25, 50, and 
100 µM vanadate for 24 h. The percentage of the cells at S phases was 13.35%, 18.45%, 
30.03 and 25.82% when the cells were treated with 10 µM, 25 µM, 50 µM, and 100 µM 
vanadate, respectively. In contrast, in p53 -/- cells, the percentage of the cells at S phases 
remained at the control levels regardless vanadate treatment times or doses (data not 
shown). 
 
Effects of vanadate on cell growth regulatory proteins   Western blotting was used 
to examine the effects of vanadate on proteins p21 and p-cdk2. Protein p21 is an 
important kinase for S phase arrest while p-cdk2 for S phase progression. In p53 deficient 
cells, vanadate did not induce a significant alternation in p21 or p-cdk2 level (data not 
shown). In C141 cells, vanadate caused an increase in p21 level with peak at 25 µM 
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(Figure 4). At the same time, vanadate inactivated phosphorylation of p-cdk2 at Thr160 
in a time- and dose-dependent manner. 
 
Effects of vanadate on ERK and p38   Western blotting was performed to study the 
effects of vanadate on ERK and p38. As shown in Figure 5, lanes 1 and 2, vanadate at 50 
µM caused phosphorylation of both ERK and p38. An increase in incubation time 
enhanced the phosphorylation (lanes 3 to 6). Vanadate-induced ERK and p38 
phosphorylation was also dose-depedent (lanes 7 to 11). 
 
Effects of vanadate on p53 activity   Luciferase assay was used to determine the 
p53 activity in C141 cells. Vanadate-induced increase in p53 activity was time dependent 
as shown in Table 1. When the C141 cells were treated with 50 µM vanadate for 6 h, the 
p53 activity increased 1.5-fold compared to the control. The relative p53 activity 
increased from 1.5-fold to 6-fold when vanadate treatment time was elongated from 6 h 
to 48 h. Vanadate treatment also caused a dose-dependent increase in p53 activity (Table 
2). It was about 5-fold when cells were treated with 100 µM vanadate for 24 h.  
 
Effects of MAPKs inhibitors on MAPKs   PD98059, an inhibitor of ERK, and 
SB202190, an inhibitor of p38, were used to determine their effects on vanadate-induced 
upregulaton of MAPKs. Figure 6 showed that treatment of the cells with 50 µM or 100 
µM PD98059 almost abolished vanadate-induced elevation of p-ERK (lanes 3 and 4). In 
contrast, SB 202190 had no effect on p-ERK (lanes 5-6). Pretreatment of the cells with 5 
µM or 10 µM SB202190 dramatically decreased of p-p38 as expected. PD 98059 did not 
inhibit it. 
 
Effects of MAPKs cell growth arrest   As shown in Figure 7, for untreated C141 
cells, the percentage of cells at S phase was 8.02% (a). Treatment of the cells with 50 µM 
vanadate for 24 h increased the S phase percentage to 30.02 (b). Pretreatment with ERK 
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inhibitor, PD98059 decreased the percentage of the C141 cells at S phase to 11.86% at 50 
µM and 8.92% at 100 µM (c and d). Similarly, addition of 5 µM or 10 µM SB202190, 
the percentage of the cells at S phase was 16.95% or 14.97% (e and f). The results show 
that inhibition of ERK or p38 decreases S phase arrest in vanadate-treated C141 cells. 
 
Effects of MAPKs cell growth regulatory proteins   As expected, pretreatment of 
C141 cells with PD98059 or SB202190 decreased vanadate-induced p21 level compared 
to the vanadate treatment alone (Figure 8). The amount of proteins was almost at the 
same level as the control without stimulation. Pretreatment of the cells with these two 
inhibitors restored vanadate-inactivated p-cdk2. 
 
Effects of MAPKs on p53 activity   As shown in Table 3, 50 µM vanadate caused 
3.7-fold increase in p53 activity. The relative p53 activity was sharply decreased when 
C141 cells were incubated with 50 µM and 100 µM PD98059, respectively. Similarly, 
pretreatment with SB also decreased the p53 activity. 
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IV.5. DISCUSSION 
 
Vanadate compounds exhibit potent toxic and carcinogenic effects on various 
biological systems. It is able to modify DNA synthesis and repair (9, 21, 42, 48), induce 
mutation and DNA-protein crosslinks (37), and inhibit tyrosine phosphatase, and 
autophosphorylate tyrosine kinase on the cell membrane receptor (56). It has been 
reported that vanadate caused DNA damage (46), and activated certain transcription 
factors, such as AP-1 (13), NF-κB (55), p53 (25), and nuclear factor of activated T cells 
(NFAT) (23). It has also been reported that vanadate is able to induce apoptosis and cell 
growth arrest (25, 54, 58). Our laboratory has shown that vanadate caused G2/M phase 
arrest through ROS-mediated reactions. The detailed mechanisms of signal transduction 
pathway involved in vanadate-induced cell growth arrest are still unclear. The results 
from present study show that: 1) vanadate caused S phase arrest in C141 cells in a time- 
and dose-dependent manner but not in p53 deficient cells; 2) vanadate up-regulated p21 
and decreased p-cdk2; 3) it activated two important members of MAPK family, ERK and 
p38; 4) vanadate increased p53 activity; 5) vanadate induced S phase arrest was 
decreased by inhibition of either ERK or p38; 6) inhibition of MAPKs decreased 
vanadate-induced p21 and restored activation of p-cdk2; and 7) inhibition of MAPKs 
reduced vanadate-induced p53 activity. 
 
Cellular stress, particularly that involving damage to the cell’s replicative 
machinery, causes delay in cell cycle progression in virtually all living organisms. The 
cell cycle delay or arrest is considered important after DNA damage, since this delay or 
arrest allows the cells time to recover and/or repair damaged DNA prior to replication 
and mitosis. Earlier studies have shown that vanadate caused G2/M arrest in T98 glioma 
cells, and both p34cdc2 and cdc25C participated in the regulation of growth arrest at this 
phase (11, 14). The results from our laboratory also indicated that vanadate caused G2/M 
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phase arrest in A549 cells through ROS-mediated reactions (58). The present study 
shows that vanadate induced S phase arrest in C141 cells. 
 
Cell cycle checkpoints monitor movement through the cell cycle, survey for cell 
damage, and induce a pause in cell cycle progression when necessary. Cyclins and 
cyclin-dependent kinases (cdks) are key regulators of the eukaryotic cell cycle (41). Cdk2 
is associated with cyclin A and cyclin E, and the respective complexes are believed to 
control S phase and the G1/S transition (17). The activity of cdk2 is regulated by an 
intricate system of protein-protein interaction and phosphorylation. The activity of this 
kinase is increased by phosphorylation of Thr160 and inhibited by phosphorylation of 
Thr14 and Tyr15. The activity of cdk2 is also negatively regulated by its binding to 
protein inhibitors. One of the important inhibitors is p21, which is downstream protein of 
p53. In addition to inhibiting the kinase activity by binding to the complex, p21 also 
blocks the phosphorylation of the activating threonine residue in cdks (3). It has been 
reported that p21 is probably sufficient for the inhibition of cdk2 (41). The results from 
present study showed that in C141 cells vanadate indeed decreased phosphorylation of 
cdk2 at Thr160. In the p53 -/- cells, vanadate treatment did not alter the percentage of the 
cells at S phase, and both p21 and p-cdk2 remained the same levels as the control without 
vanadate stimulation (data not shown). 
 
MAPKs play a pivotal role in the regulation of cell growth arrest, survival, 
differentiation, and apoptosis (15, 36). Once they are activated, MAPKs regulate gene 
expression through phosphorylation of downstream transcription factors. Generally, 
activation of ERK cascade is involved in mitogenesis and differentiation, whereas both 
p38 and JNK are believed to mediate cell growth arrest and apoptosis (15, 36). In 
Xenopus egg, ERK is activated during the cells arrested in M phase. Addition of 
PD98059 decreased the M phase arrest (5). Another study showed that PD98059 reverted 
the G1 phase arrest as well as pRB hyperphosphorylation induced by the growth 
inhibition agent TPA (1). Furthermore, inhibition of ERK kinase activity substantially 
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abrogates the UV induction of the GADD45 promoter that is important checkpoint 
responsible for G2/M phase arrest (52). The results from our laboratory also showed that 
ERK was involved in vanadate-induced G2/M phase arrest (unpublished observation). In 
contrast, a previous study also found that persistently activated ERK may cause 
unregulated growth of fibroblasts and tumor formation in mice (31). The inhibition of 
ERK activity induced a dose-dependent growth arrest in G0/G1 phase with upregulation 
of cdk2 and hypophosphorylation of RB (27). The present study showed that vanadate 
activated phosphorylation of ERK as early as 0.5 h. Addition of PD98059 not only 
decreased vanadate-induced S phase arrest, but also reduced the p21 level and restored p-
cdk2 inactivated by vanadate, suggesting that ERK is involved in vanadate-induced S 
phase arrest in C141 cells. In addition, the importance of p38 in cell growth became 
apparent due to the observation that overexpression of p38 in yeast led to significant 
decrease in proliferation (60). The p38 was activated in cultured mammalian cells when 
these cells were arrested in M phase by disruption of the spindle with nocodazole (50). 
Activation of p38 is also believed to be involved in the spindle assembly checkpoint of 
somatic cell cycles (35). G1 arrest in NIH3T3 cells caused by microinjection of cdc42 is 
p38-dependent (35). Disruption of fission yeast p38 cascades, Wis1-Spc/Sty1, lead to cell 
size enlargement and cell division arrest, suggesting that the Wis1-Spac1 MAPK cascade 
is linked to the G2/M cell cycle control mechanism (47). The regulation of cdc25B 
phosphorylation by p38 is a critical event for initiating the G2/M phase checkpoint after 
UV exposure (7). The present study indicates that p38 was activated by the vanadate 
treatment in a time- and dose-dependent manner. Inhibition of p38 phosphorylation by 
SB202190 decreased vanadate-induced S phase arrest. Similarly, p38 is also involved in 
vanadate-regulated protein p21 and p-cdk2. 
 
p53 mediates several cellular functions such as induction of cell cycle arrest or 
apoptosis in response to DNA damage and helps to preserve genetic stability (51). It has 
been reported that p53-dependent cell growth arrest in G1 phase is an important 
component of the cellular response to stress (51). A recent study indicates that p53 
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controls the entry into mitosis when cells enter G2 phase with damaged DNA or when 
they are arrested in S phase due to depletion of the substrates required for DNA synthesis 
(10). It has been reported that activation of p53 following DNA damage induces 
expression of p21, which in turn may be responsible for the cell cycle arrest (41). In 
addition, inhibition of either ERK or p38 decreased the p53 activity induced by vanadate. 
The p53 activation correlated with prominent activation of ERK1/2 MAP kinases that 
resulted from colcemid-stimulated development of focal adhesions that caused G1 phase 
arrest (43). It has also been reported that phosphorylation of p53 by p38 plays a role in 
p53-dependent transcription (24). 
 
In summary, vanadate induced S phase arrest in p53 wild type C141 cells, 
upregulated p21, and inactivated cdk2. Vanadate caused activation of both ERK and p38. 
Vanadate also increased p53 activity. The inhibition of either ERK or p38 decreased 
vanadate-induced S phase arrest, reduced p21 level and p53 activity, and increased 
phophorylation of cdk2. The present study indicates that vanadate-induced S phase arrest 
is mediated by MAPKs through p53-dependent pathway. 
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IV.6. FIGURES 
 
 
 
 
 
 
Figure 1   Leakage of cytosolic lactate dehydrogenase (LDH) from C141 cells exposed to 
various concentrations of vanadate for 24 h. Each point represents mean ± SD 
of three independent experiments. 
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Figure 1   Leakage of cytosolic lactate dehydrogenase (LDH) from C141 cells exposed to 
to 50 µM vanadate for various times. Each point represents mean ± SD of three 
independent experiments. 
0
10
20
30
40
50
0 12 24 36 48
L
D
H
 L
ea
ka
ge
 (%
)
Time (h)
B 
128
 
 
 
 
 
Figure 2   Time dependence of vanadate-induced cell growth arrest in C141 cells. C141 
cells were suspended in 5% fetal bovine serum (FBS) MEM in a 100 mm 
dish. After 80% confluence, cells were washed with PBS three times, and 
treated with 50 µM vanadate for various times. a, control; b, 6 h; c, 12 h; d, 24 
h; and e, 48 h. Cells were harvested and DNA content was measured by flow 
cytometry. Data are from a single preparation representative of three 
independent experiments. 
a b c
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Figure 3   Concentration dependence of vanadate-induced cell growth arrest in C141 
cells.  These cells were suspended in 5% fetal bovine serum (FBS) MEM in a 
100 mm dish.  After 80% confluence, cells were washed with PBS three 
times, and treated with vanadate at various concentration for 24 h.  a, control; 
b, 10 µM; c, 25 µM; d, 50 µM, and e, 100 µM.  Cells were harvested and 
DNA content was measured by flow cytometry. Data are from a single 
preparation representative of three independent experiments. 
a b c
d e
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Figure 4   Effects of vanadate on growth regulatory proteins in C141 cells. The cells were 
treated with 50 µM vanadate for 6, 12, 24 and 48 h and 10, 25, 50, 100 µM for 
24 h. The whole cell lysates were collected for Western blotting using specific 
antibodies against p-cdk2 and p21. Lanes 1 and 6, control; lanes 2, 50 µM 6 h; 
lane 3, 50 µM, 12 h; lanes 4 and 9, 50 µM, 24 h; lane 5, 50 µM, 48 h; lane 7, 
10 µM, 24 h; lane 8, 25 µM, 24 h; and lane 10, 100 µM, 24 h. Data are from a 
single preparation representative of three independent experiments. 
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Figure 5   Activation of p38 and ERK by vanadate in C141 cells. C141 cells were seeded 
in 6-well plate. Western blotting was performed as described in detail in the 
Materials and Methods. Lanes 1 and 7, control; lane 2, 50 µM, 0.5 h; lane 3, 50 
µM, 1 h; lanes 4 50 µM, 2 h; lanes 5 and 10, 50 µM, 4h; lane 6, 50 µM, 8 h; 
lane 8, 10 µM, 4 h; lane 9, 25 µM, 4 h; and lane 11, 100 µM, 4 h. Data are 
from a single preparation representative of three independent experiments. 
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          Table 1   Time dependence of vanadate-induced p53 activity1 
  
  Incubation time (h)       Relative p53 activity 
 
     6    1.44 ± 0.23 
   12    2.15 ± 0.19 
   24    3.71 ± 0.382 
   48    5.33 ± 0.532 
 
 
1. 1 × 104 cells were seeded into 96-well plate with 100 µl medium each well. The 
cells were treated with 50 µM vanadate for various times. The cells were 
extracted with lysis buffer. The p53 luciferase activity was measured using a 
luminomater (Moonlight 3010). The results were expressed as p53 activity 
relative to control. Each point represents mean ± SD of three independence 
experiments. 
2. p<0.05 compared to control (one-way ANOVA with Scheffe’s test). 
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          Table 2   Dose-dependence of vanadate-induced p53 activity1 
  
  Vanadate concentration (µM)  Relative p53 activity 
 
   10         1.61 ± 0.28 
   25         2.64 ± 0.322 
   50         3.71 ± 0.382 
   100         5.44 ± 0.662 
 
 
1. 1 × 104 cells were seeded into 96-well plate with 100 µl medium each well. The 
cells were treated with vanadate at various concentrations for 24 h. The cells were 
extracted with lysis buffer. The p53 luciferase activity was measured using a 
luminomater (Moonlight 3010). The results were expressed as p53 activity 
relative to control. Each point represents mean ± SD of three independence 
experiments. 
2.   p<0.05 compared to control (one-way ANOVA with Scheffe’s test) 
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Figure 6   Inhibitory effects of PD98059 and SB202190 on vanadate-activated ERK and 
p38 in C141 cells. C141 cells were incubated in 6-well plate in MEM medium 
containing 5% FBS. The cells were pre-treated with PD or SB for 0.5 h prior 
to vanadate treatment (4 h). The whole cell lysates were used to analyze 
phospho-p38 and ERK by Western blotting. Lane 1, control without vanadate; 
lane 2, 50 µM vanadate; lane 3, 50 µM vanadate + 50 µM PD; lane 4, 50 µM 
vanadate + 100 µM PD; lane 5, 50 µM vanadate + 10 µM SB; and lane 6, 50 
µM vanadate + 20 µM SB. Data are from a single preparation representative 
of three independent experiments. 
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Figure 7   Effects of MAPKs inhibitors on vanadate-induced cell growth arrest in C141 
cells. The cells were incubated in a 100 mm dish and pretreated with PD98059 
or SB202190 for 0.5 h before vanadate treatment (50 µM, 24 h). After 24 h, 
cells were harvested, and DNA content was measured by flow cytometry. a, 
control without vanadate treatment; b, 50 µM vanadate; c, 50 µM vanadate + 
50 µM PD; d, 50 µM vanadate + 100 µM PD; e, 50 µM vanadate + 10 µM 
SB; and f, 50 µM vanadate + 20 µM SB. Data are from a single preparation 
representative of three independent experiments. 
a b c
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Figure 8   Inhibitory effects of MAPKs inhibitors on vanadate-regulated growth proteins 
in C141 cells. The cells were incubated in 6-well plate. These cells were pre-
treated with PD or SB for 0.5 h before vanadate stimulation (50 µM, 4 h). The 
whole cell lysates were collected for Western blotting using specific antibodies 
against p-cdk2 and p21. Lane 1, control; lane 2, 50 µM vanadate; lane 3, 50 
µM vanadate + 50 µM PD; lane 4, 50 µM vanadate + 100 µM PD; lane 5, 50 
µM vanadate + 10 µM SB; and lane 6, 50 µM vanadate + 20 µM SB. Data are 
from a single preparation representative of three independent experiments. 
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Table 3 Effects of MAPKs on p53 activity1 
  
  MAP kinase inhibitors   Relative p53 activity 
 
     0        3.71 ± 0.38 
   50 µM PD       0.95 ± 0.172 
            100 µM PD       0.42 ± 0.152 
     5 µM SB       0.87 ± 0.232 
   10 µM SB       0.24 ± 0.062 
 
 
1. 1 × 104 cells were incubated in 96-well plate. The cells were pretreated with 
PD98059 or SB202190 for 0.5 h prior to vanadate (50µM) stimulation. After 24 
h, the cells were extracted with lysis buffer. The p53 luciferase activity was 
measured using a luminomater (Moonlight 3010). The results were expressed as 
p53 activity relative to control. Each point represents mean ± SD of three 
independence experiments. 
2. p<0.05 compared to vanadate treatment (one-way ANOVA with Scheffe’s test). 
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SECTION V 
 
 
Involvement of E2F1-pRb in Vanadate-induced S Phase Arrest through 
Akt Pathway 
146
V.1. ABSTRACT 
 
Protein kinase B (PKB)/Akt and its upstream signal transducer, 
phosphatidylinosito-3 kinase (PI3K) play an essential role in control of transcription and 
translation, which impact on cell growth, survival and metabolism. Transcription factor 
E2F is a component of the downstream proliferative machinery regulated by Akt. 
Hyperphosphorylation of retinoblastoma protein (pRb), a pocket protein, leads to release 
of E2F1, resulting in transition of G1 to S phase. The present study shows that in normal 
C141 cells, vanadate treatment increased the percentage of cells at S phase and elevated 
cyclin E and cyclin A expression. Vanadate treatment triggered phosphorylation of pRb 
and release of E2F1. Furthermore, vanadate increased Akt kinase activity and caused 
phosphorylation at Ser473 and Thr308. Inhibition of Akt by either inhibitors or 
transfected cells with dominant negative kinase mutant or dominant negative 
phosphorylation mutant decreased the percentage of the cells at the S phase induced by 
vanadate, and reduced both cyclin E and E2F1 expression and phosphorylation of pRb. 
The present study indicates that Akt plays an essential role in vanadate-induced S phase 
arrest and transition from G1 to S phase through E2F-pRb pathway. 
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V.2. INTRODUCTION 
 
Mammalian cells require an extracellular proliferative signal directly after mitosis 
in order to keep on growing and dividing. When cells are faced with a lack of such signal, 
they will either die or go into growth arrest in a postmitotic G1 phase. One of the 
important intracellular signaling pathways that transduce such proliferative signals is 
phosphatidylinositol-3 kinase (PI3K) pathway (1). The proto-oncogene protein kinase 
(PKB), known as Akt, is a major target of PI3K signaling in the control of cell 
proliferation, as it is involved in anti-apoptotic signaling as well as cell cycle control (2). 
PKB/Akt is the cellular homologue of the transforming viral oncogene v-Akt and bears 
significant homology to PKA and PKC (3). The three mammalian isoforms, α, β and γ, 
all contain an N-terminal PH domain, a central kinase domain with an activation-loop 
Thr308 phosphorylation site, and a conserved, regulatory serine phosphorylation site, 
Ser473 near the C terminus (4). The full activation of Akt kinase requires the 
phosphorylation at these two sites (4). 
 
Although the mechanisms by which PKB contributes to the regulation of 
apoptosis have become better defined, relatively little is known concerning its role in the 
regulation of cell cycle progression (2). A recent study has demonstrated that the cell-
cycle regulator E2F is a component of the downstream proliferative machinery regulated 
by Akt (5). One of the key events in G1 phase is the activation of E2F, which in turn 
binds to promoters and trans-activates various genes critical for cell cycle progression, 
such as cyclin E (2). The E2F family of transcription factors are important regulators of 
the G1/S cell cycle transition, because E2F can activate expression of the S phase 
regulatory genes necessary for initiating DNA replication (6). E2F is a repressor when 
complexed with a member of the retinoblastoma (Rb) family of pocket proteins (7,8). 
The continuation of cell proliferation at various stages of the cell cycle involves 
inactivation of at least one of three members of the Rb family (1). The pRb protein is an 
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essential component of the G1/S checkpoint (9). pRb is present at relatively constant 
levels throughout the cell cycle but is hyperphosphorylated by cyclin/cdk complexes and 
released from E2F1 at the G1/S transition, allowing continuation through the cell cycle 
(10). 
 
Vanadate is widely found in occupational and environmental systems. 
Epidemiological studies have shown a correlation between vanadium exposure and the 
incidence of lung cancer in humans (11-13). Vanadium compounds were reported to 
modify DNA synthesis and repair (11,13,14), and induce mutations and DNA-protein 
crosslinks (14-18). Vanadate is able to induce G2/M phase arrest through reactive oxygen 
species (ROS) in A549 cells (19). A recent study from our group also indicated that 
vanadate caused p53 dependent S phase arrest in mouse epidermal JB6 cells (20). Our 
study has shown that vanadate induced expression of both hypoxia-inducible factor 1 
(HIF-1) and vascular endothelial growth factor (VEGF) is through PI3K/Akt pathway in 
DU145 human prostate carcinoma cells and ROS play an important role (unpublished 
observations). 
 
The purposes of the present study are: (a) to investigate the effect of vanadate on 
cell cycle arrest; (b) to study the involvement of cell cycle regulatory proteins in the 
vanadate-induced cell cycle arrest; (c) to examine whether vanadate is able to activate 
Akt; and (d) to explore the effect of Akt in vanadate-induced cell cycle arrest and its 
regulation. 
149
V.3. MATERIALS AND METHODS 
 
Chemicals   Sodium metavanadate was from Aldrich (Milwaukee, WI). RNase A 
and Eagle’s minimal essential medium (MEM) were from Sigma (St. Louis, MO). Fetal 
bovine serum (FBS) was from Gibco BRL (Life Technologies, Gaithersburg, MD). 
LY294002, wortmanin were from Calbiochem (San Diego, CA). Dominant negative 
Akt1 cDNA plasmid was from Upstate (Lake Placid, NY). Antibodies against cyclin E, 
cyclin A and E2F1 were from Santa Cruz Biotechnology (Santa Cruz, CA). Antibodies 
against phospho-Rb, Akt and second AP linked anti-rabbit IgG, and Akt kinase assay kit 
were from Cell Signaling (Beverly, MA).  
 
Cell culture   The JB6 P+ mouse epidermal cell line, C141 cell, and its stable 
transfection with dominant negative Akt phosphorylation sites mutant (SRα-Akt-
T308A/S473A) cells, DN/P cells, and its stable transfection with dominant negative Akt 
kinase domain mutant (L179M) cells, DN/K cells were cultured in MEM medium 
containing 5% FBS, 2 mM L-glutamine and 1,000 U/ml penicillin-streptomycin in an 
incubator at 5% CO2 and 37°C. 
 
Measurement of cell cycle/DNA content   DNA content in G1/S, G2/M phase was 
measured using flow cytometry (21,22). C141 cells, DN/K cells and DN/P cells were 
fixed and permeabilized with 70% ice-cold ethanol, and incubated with the freshly 
prepared staining buffer (0.1% Triton X-100 in PBS, 200 µg/ml RNase A, and 20 µg/ml 
PI) for 15 min at room temperature. Cell cycle analysis was performed by flow cytometry 
with at least 10,000 cells for each sample. The histogram was abstracted and the 
percentages of cells in the G1/S and G2/M phase were then calculated using ModFit LT 
software. 
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Western blotting analysis   The cells were seeded in 100 mm dishes. Cells were 
lysed in RIPA buffer (150 mM NaCl, 100 mM Tris (pH 8.0), 1% Triton X-100, 1% 
deoxycholic acid, 0.1% SDS, 5 mM EDTA and 10 mM NaF) supplemented with 1 mM 
sodium vanadate, 2 mM leupeptin, 2 mM aprotinin, 1 mM phenylmethylsulfonyl fluoride 
(PMSF), 1 mM DTT, and 2 mM pepstatin A on ice for 30 min. After centrifugation at 
14,000 rpm for 5 min, the supernatant was harvested as the protein extract. The protein 
concentration was determined using Bio-Rad protein assay reagent (Richmond, CA). The 
protein extracts were run by Tris-Glycine SDS gel electrophoresis, and transferred to 
PVDF membrane. Western blotting was performed using antibodies against cyclin E, 
cyclinA, E2F, phospho-Rb, Akt and second anti-rabbit IgG. After reaction with ECF 
substrate, the signal was detected using a Storm Scanner (Molecular Dynamics, 
Sunnyvale, CA). 
 
Akt kinase assay   Cells were rinsed once with ice-cold PBS and scraped from the 
plates, and centrifuged at 4,000 rpm for 5 min. The cell pellet was incubated for 10 min 
on ice in lysis buffer (150 mM NaCl, 20 mM Tris-HCl (pH 7.5), 1% Triton X-100, 1 mM 
EDTA, 1 mM EGTA, 2.5 mM sodium pyrophosphate, 1 mM β-Glycerolphosphate, 1 
mM Na3VO4, 1 µg/ml leupeptin) supplemented with 1 mM PMSF, and centrifuged at 
11,000 rpm for 10 min to clarify the supernatants. 200 µg of protein extracts were 
incubated with 20 µl of resuspended immobilized Akt antibody slurry gentle rocking 3 h 
at 4°C. The pellets were washed twice with lysis buffer and kinase buffer (25 mM Tris 
(pH7.5), 5 mM β-Glycerolphosphate, 2 mM DTT, 0.1 mM Na3VO4, 10 mM MgCl2), 
respectively. Then the pellets were suspended in 40 µl kinase buffer supplemented with 
200 µM ATP and 1 µg GSK-3 fusion protein, and were incubated 30 min at 30°C. 20 µl 
3 × SDS sample buffer (187.5 mM Tris-HCl (pH 6.8 at 25°C), 6% SDS, 30% glycerol, 
150 mM DTT, 0.03% bromphenol blue) was added to terminate the reaction, followed by 
spinning at 11,000 rpm for 2 min. The supernatant was transferred to new tube and boiled 
for 5 min. Western blotting was performed to probe phospho-GSK-3α/β antibody. 
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V.4. RESULTS 
 
Effects of vanadate on cell cycle in C141 cells   DNA content was used to analyze 
the percentage of the cells at S phase. Figure 1, panel A shows that in C141 cells 50 µM 
vanadate causes a time-dependent increase in S phase from 0 to 24 h. The percentage of 
the cells at S phase was 7.60% at beginning of vanadate stimulation, and it was 34.79% at 
24 h. Similarly, a dose-dependency was observed from 0 to 50 µM vanadate treatment 
(panel B). The peaks of S phase appeared at 50 µM vanadate treatment for 24 h. 
 
 Effects of the vanadate on cell growth regulatory proteins in C141 cells   To study 
the effects of vanadate on cell growth regulatory proteins, Western blotting was used to 
the expression of cyclin E, cyclin A, and E2F1, and phoshpo-Rb in C141 cells. Figure 2 
shows that vanadate caused a time- and dose-dependent increase in cyclin E, cyclinA, and 
E2F1 level, and phosphorylation of Rb. 
 
 Effects of vanadate on Akt in C141 cells   Both the kinase assay and Western 
blotting were used to examine the effects of vanadate on both Akt kinase activity and its 
phosphorylation in the present study. As shown in Figure 3, 50 µM vanadate caused a 
time-dependent increase of Akt activity (phospho-GSK-3α/β) (panel A). Similarly, Akt 
activity was increased with the increase in dose (panel A, lanes 7 to 11). In addition, both 
the phosphorylations at Ser473 and Thr308 were activated in vanadate-treated cells (panel 
B). Phosphorylation of Akt was increased with the vanadate treatment time (0 to 240 min 
at 50 µM). Similar results were obtained when the cells were treated with different doses 
of vanadate (from 0 to 100 µM for 120 min). 
 
 Effects of Akt on cell cycle arrest   As shown in Figure 4, panel A, the two PI3K 
inhibitors, LY294002 and wortmanin, significantly inhibited vanadate-induced S phase 
arrest in C141 cells. The higher the dose of inhibitors, the less the percentage of cells at S 
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phase. In DN/K cells, although vanadate caused increase in S phase in a time- and dose-
dependent manner, the fold of increase was significantly reduced (panels B-C). The 
percentage of S phase is 3.75% in untreated cells and the highest is 8.27% in cells treated 
with 50 µM vanadate for 48 h (panel B). The Similar effect was also observed in panel C 
as the cells were treated with different doses. In the DN/P cells, it is 2.7-fold of increase 
in S phase when cells were treated with 50 µM vanadate for 24 h compared to the control 
cells without stimulation (panel D). In the panel E, the percentage of cells at S phase is 
4.38%, 5.58%, 8.13%, 11.61%, and 13.42% when the cells were stimulated with vanadate 
at 0, 10 µM, 25 µM, 50 µM, and 100 µM for 24 h, respectively. The fold of S phase arrest 
in DN/P cells is between that in wild type cells and in DN/K cells. 
 
 Effects of Akt on cell growth regulatory proteins   Both LY294002 and wortmanin 
reduced vanadate-induced cyclin E, cyclin A, and E2F1 expression, and the 
phosphorylation of Rb in C141 cells (Figure 5, panel A, lanes 3-6). Both kinase mutant 
and phosphorylation mutant partially reduced vanadate-induced cyclin E expression 
(Figure 5, panels B and C). Cyclin E level increased by vanadate treatment in DN/P cells 
is between that in C141 wild type cells (Figure 2) and DN/K cells (Figure 5, panel B and 
C). In both DN/K and DN/P cells, cyclin A level had no observable change compared to 
the C141 wild type cells (Figure 2). In DN/K cells, both E2F1 expression and 
phosphorylation of pRb were at the same low levels regardless vanadate treatment. While 
E2F1 expression and phosphorylation of pRb slightly increased in DN/P cells treated with 
vanadate compared to those in wild type cells (Figure 2), they remained in very low 
levels. 
 
 Effects of PI3K on Akt activity   PI3K is an upstream kinase of Akt. In this section, 
we examined the effect of PI3K on Akt activity. As shown in Figure 6, wortmanin and 
LY294002 completely blocked Akt activity in vanadate-treated C141 cells (panel A, lanes 
3-6). Vanadate had no effect on Akt activity in DN/K cells regardless the treatment times 
and doses (panel B, lanes 1-11). Akt activity was slightly increased in DN/P cells treated 
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with vanadate (panel B, lanes 1-11), although the level of increase was much reduced 
compared to that in wild type cells (Figure 3, panel A). 
 
 Effectsof PI3K on Akt phosphorylation   Both LY294002 and wortmanin 
completely blocked the phosphorylation of Akt at Ser473 (Figure 7, panel A). LY294002 
did not have any observable inhibitory effect on the phosphorylation of Akt at Thr308 
(lanes 3 and 4). In DN/K cells, vanadate-induced phosphorylation at Ser473 and Thr308 
(Panels B and C, left part) was much lower than that in wild type cells (Figure 3). In 
DN/P cells, vanadate failed to activate phosphorylation of Akt at these two major sites 
(panel B and C, right part). 
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V.5. DISCUSSION 
 
Vanadate compound is widespread in the both environmental and biological 
systems. It exerts potent toxic and carcinogenic activity. It has been reported that 
vanadium can regulate growth-factor-mediated signal transduction pathways, promote 
cell transformation (23,24). Workers occupationally exposed to vanadium are at risk as 
respirable particulates may penetrate deep into pulmonary tract. Epidemiological studies 
have shown a correction between vanadium exposure and lung cancer in humans (15,17). 
 
Characterization of cell cycle regulation is important for understanding how 
extracellular stimuli affect on cell proliferation. Previous studies have shown that 
vanadate is able to induce S phase arrest in C141 (20). This S phase arrest is p53-
dependent through activation of p21 and mitogen-activated protein kinase (MAPK) signal 
transduction pathway (20). The present study shows that vanadate treatment caused 
increase in the percentage of cells at S phase in a dose- and time-dependent manner. 
Cyclin E/cdk2 complex plays a crucial role in the G1/S phase transition (25). The 
expression and activity of cyclin E follows that of cyclin D, with increase in cyclin E 
expression occurring in the nuclus in early G1, peaking at the G1/S border, and declining 
thereafter (26,27). In contrast, cyclin A activity is thought to contribute to the G1/S 
transition, S phase progression and G2/M transition (25). The present study shows that 
vanadate treatment is able to cause increase in cylin E and cyclin A expression in a dose- 
and time-dependent manner. 
 
PKB/Akt is activated via a multistep process by a variety of signals. In the early 
steps of this process, PI3K-generated D3-phosphorylated phosphoinositides bind to the 
Akt PH domain and induce the translocation of the kinase to the plasma membrane where 
it co-localizes with phosphoinositide-dependent kinase-1. D3-phosphorylated 
phosphoinositides also appear to induce conformational changes that permit 
phosphoinositide-dependent kinase-1 to phosphorylate the activation loop of Akt (28). 
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Signals induced by stress as well as by beta-adrenergic receptor agonists such as 
isoproterenol and cAMP have been shown to activate Akt in a PI3K independent manner 
(29-31). However, it has been reported that the activation of Akt by stress such as 
hydrogen peroxide, a key member of ROS, or heat stock was PI3K dependent (32). UV 
induced phosphorylation of Akt at Ser473 and Thr308 in C141 cells was through 
hydrogen peroxide (33). Vanadate was able to generate ROS, which were involved in 
vanadate-induced G2/M phase arrest (19). Recent study from our group also shows that 
vanadate induced HIF-1 and VEGF expression was through ROS and PI3K/Akt pathway 
(unpublished observations). The present study shows that vanadate stimulation not only 
increased Akt kinase activity, but also caused phosphorylation of Akt at Ser473 and 
Thr308 in a dose- and time-dependent manner. Addition of two PI3K inhibitors, 
LY294002 and wortmanin, reduced vanadate-induced Akt kinase activity and its 
phosphorylation. These results indicate that vanadate-induced Akt activation was PI3K 
dependent. Moreover, the Akt activity induced by vanadate was blocked in the cells 
transfected with dominant negative Akt kinase mutant plasmid. In addition, vanadate 
failed to phosphorylate Akt at Thr308 because activation loop of Thr308 is located in the 
kinase domain, and mutation at kinase domain affects the function of phosphorylation. 
However, the phosphorylation at Ser473 was also affected in this type of cells. There are 
two models of Akt activation. a) Akt is cytosolic, and moves to the plasma membrane in 
response to PI3K induction (34,35). Ser473 phosphorylation occurs at the membrane. 
This region forms a docking site for protein dependent kinase-1 (PDK1), which binds and 
phosphorylates Thr308 (36). b) cytosolic Akt and PDK1 are colocalized, but Akt is 
inactive due to constraints imposed by its PH domain (37). Growth factors stimulate 
PI3K, which draws both PDK1 and Akt to the plasma membrane. The PH domain of Akt 
binds to phosphatidylinositol-3,4,5-trisphosphate (PtdIns(3,4,5)P3), unmasking the 
activation loop and allowing PDK1 to phosphorylate Thr308 (37). Subsequent elevation 
of Akt activity promotes autophosphorylation of Ser473 or phosphorylation by a third-
party of enzyme, PDK2 (38). Akt is fully activated (39). This is likely that vanadate-
activated Akt is through the later model. Akt kinase domain mutation affects its 
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phosphorylation at Thr308, which in turn affects phosphorylation at Ser473. Similarly, 
transfection with dominant negative mutant SRα-Akt-T308A/S473A made the cells 
being unable to be phosphorylated by vanadate. Again the induction of Akt activity by 
vanadate in this type of cell is less potent than that in wild type cell. That is because 
Thr308 is located in kinase domain, and mutation of Thr308 affects the kinase activity. 
 
The mammalian cell cycle is a highly regulated process that is influenced by both 
positive and negative growth-regulatory signals during the G1 stage (40). These signals 
act by controlling the transcriptional activity of a cellular transcription factor E2F. 
Activation of E2F is sufficient to irreversibly commit cells to undergo DNA replication. 
Thus E2F is crucial in the control of cellular proliferation in both normal and tumor cells 
(41). The E2F family determines whether or not a cell will divide by controlling the 
expression of key cell-cycle regulators. These encoded cell cycle regulators include 
cyclin E, cyclin A, cdc2, cdc25A, pRb, and E2F1 (6). The E2F family is divided into two 
distinct groups: E2Fs (E2F1-6) and the DPs (DP1 and DP2) (41). E2F1 is believed to act 
as a tumor suppressor through its ability to induced apoptosis and cell cycle regulation. It 
participates in the repression of E2F-responsive genes through recruitment of pRb (42). 
However, recent studies indicate that E2F1 might also be involved in the DNA-damage-
response pathway (43). Other studies showed that E2F1 is phosphorylated by the DNA-
damage-response kinase, ataxia-telangiectasia mutated (ATM) and ataxia-telangiectasia 
and Rad3-related (ATR), leading to its stabilization. In the present study, vanadate 
treatment caused phosphorylation of pRb, which in turn caused itself being inactivated, 
leading to release of E2F1 (44). Activated E2F therefore triggers the regulation of cyclin 
E, cyclin A. 
 
It has been shown that dominant negative PI3K and pharmacological inhibitors of 
PI3K completely abrogate IL-2 induced E2F (5). Furthermore, expression of gag-PKB 
also induced a strong transcriptional activation of E2F, suggesting that these proliferation 
effects are indeed mediated via PKB. Another study has shown that activated PI3K 
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induced cyclin D1 transcription and E2F activity, at least in part mediated by Akt, 
suggesting that the PI3K/Akt pathway contributed to the G1 cell cycle progression (45). 
In addition, it has been reported that Ras-induced increase in E2F1 levels is dependent on 
Akt in HEK293 cells (46). The present study shows that upon vanadate stimulation, 
cyclin E/cdk2 complex may trigger the phosphorylation of pRb. The 
hyperphosphorylated pRb in turn caused release of E2F1, promoting the transition of G1 
to S phase. Addition of either LY294002 or wortamnin reduced the expression of cyclin 
E and cyclin A, and decreased phosphorylation of pRb induced by vanadate, resulting in 
being unable to release E2F1. In addition, cyclin level in DN/P cells was higher than that 
in DN/K cells, but lower than that in wild type cells. However, the mutation of kinase 
domain or phosphorylation sites seemed to have no effect on cyclin A level. Inhibition of 
kinase activity by transfection of the cells with dominant negative kinase mutant made 
vanadate being unable to phosphorylate pRb. In contrast, inhibition of phosphorylation 
could not completely block phosphorylation of pRb or E2F1 expression induced by 
vanadate. This result is consistent with the expression of cyclin E. It is likely that other 
Akt phosphorylation sites beyond Ser473 and Thr308 can regulate cyclin E. Due to the 
decreased cyclin E level after inhibition of either kinase activity or phosphorylation, the 
percentage of cells at S phase induced by vanadate decreased in both DN/K cells and 
DN/P cells compared to the wild type cells. Moreover, in the control cells without 
stimulation, transfection with either dominant negative Akt mutant plasmid or dominant 
negative T308A/S473A mutant plasmid decreased the S phase arrest compared to the 
wild type cells. These observations indicate that both transition of G1/S phase and S 
phase progression are mediated by Akt. 
 
In summary, (a) Vanadate promoted transition of G1/S and arrested the cells at S 
phase; (b) Vanadate caused increase in cyclin E and cyclin A expression; (c) Vanadate 
triggered phosphorylation of pRb and release of E2F1; (d) Vanadate increased both Akt 
kinase activity and caused its phosphorylation at Ser473 and Thr308; and (e) The 
inhibition of Akt decreased the vanadate-induced cell cycle arrest at S phase, and reduced 
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both cyclin E and E2F1 expression and phosphorylation of pRb. The present study 
indicated that PI3K/Akt signaling plays an essential role in vanadate-induced S phase 
arrest through E2F1-pRb pathway. 
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V.6. FIGURES 
 
 
 
 
 
 
Figure 1   Effects of vanadate on cell cycle arrest at S phase in C141 cells. C141 cells 
were seeded in 5% fetal bovine serum (FBS) MEM in a 100 mm dish. After 
80% confluence, cells were treated with 50 µM vanadate for 6, 12, 24 and 48 
h. DNA content was measured by flow cytometry. Each point represents mean 
± SD of three independent experiments. *, p<0.05 compare to control (one-
way ANOVA with Scheffe’s test). 
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Figure 1   Effects of vanadate on cell cycle arrest at S phase in C141 cells. C141 cells 
were seeded in 5% fetal bovine serum (FBS) MEM in a 100 mm dish. After 
80% confluence, cells were treated with 10, 25, 50, 100 µM vanadate for 24 h. 
DNA content was measured by flow cytometry. Each point represents mean ± 
SD of three independent experiments. *, p<0.05 compare to control (one-way 
ANOVA with Scheffe’s test). 
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Figure 2   Effects of vanadate on cell growth regulatory proteins in C141 cells. The cells 
were treated with 50 µM vanadate for 6, 12, 24 and 48 h and 10, 25, 50, and 
100 µM for 24 h. The whole cell lysates were collected for Western blotting 
using specific antibodies against cyclin E, cyclin A, E2F1 and phospho-Rb. 
Lanes 1 and 6, control; lane 2, 50 µM, 6 h; lane 3, 50 µM, 12 h; lanes 4 and 9, 
50 µM, 24 h; lane 5, 50 µM, 48 h; lane 7, 10 µM, 24 h; lane 8, 25 µM, 24 h; 
and lane 10, 100 µM, 24 h. Data are from a single preparation representative of 
three independent experiments. 
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Figure 3   Effects of vanadate on Akt. The cells were treated with 50 µM vanadate from 0 
to 240 min and 10, 25, 50, and 100 µM for 120 min. The whole cell lysates 
were used to measure the kinase activity and phosphorylation. Panel A and 
panel B represent Akt kinase activity and phosphorylation of Akt, respectively. 
Lanes 1 and 7, control; lane 2, 50 µM 15 min; lane 3, 50 µM, 30 min; lanes 4, 
50 µM, 60 min; lanes 5 and 10, 50 µM, 120 min; lane 6, 50 µM, 240 min; lane 
8, 10 µM, 120 min; lane 9, 25 µM, 120 min; and lane 11, 100 µM, 120 min. 
Data are from a single preparation representative of three independent 
experiments. 
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Figure 4 Effects of Akt on cell cycle arrest. The C141 cells were pretreated with 
different concentrations of LY294002 and wortmanin for 30 min prior to 
vanadate treatment (50 µM for 24 h). DNA content was used to measure the 
percentage of the cells at S phase. Lane 1, control; lane 2, 50 µM vanadate; 
lane 3, 50 µM vanadate + 10 µM LY; lane 4, 50 µM vanadate + 20 µM LY; 
lane 5, 50 µM vanadate + 50 nM wortmanin; and lane 6, 50 µM vanadate + 
100 nM wortmanin. Each point represents mean ± SD of three independent 
experiments. *, p<0.05 compare to control (one-way ANOVA with Scheffe’s 
test). 
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Figure 4   Effects of Akt on cell cycle arrest. DN/K cells were treated with 50 µM 
vanadate for 0, 6, 12, 24 and 48 h. DNA content was used to measure the 
percentage of the cells at S phase. Each point represents mean ± SD of three 
independent experiments. *, p<0.05 compare to control (one-way ANOVA 
with Scheffe’s test). 
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Figure 4   Effects of Akt on cell cycle arrest. DN/K cells were treated with 0, 10, 25, 50, 
and and 100 µM vanadate for 24 h. DNA content was used to measure the 
percentage of the cells at S phase. Each point represents mean ± SD of three 
independent experiments. *, p<0.05 compare to control (one-way ANOVA 
with Scheffe’s test). 
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Figure 4   Effects of Akt on cell cycle arrest. DN/P cells were treated with 50 µM 
vanadate for 0, 6, 12, 24, and 48 h. DNA content was used to measure the 
percentage of the cells at S phase. Each point represents mean ± SD of three 
independent experiments. *, p<0.05 compare to control (one-way ANOVA 
with Scheffe’s test). 
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Figure 4   Effects of Akt on cell cycle arrest. DN/P cells were treated with 0, 10, 25, 50, 
and 100 µM vanadate for 24 h. DNA content was used to measure the 
percentage of the cells at S phase. The cells Each point represents mean ± SD 
of three independent experiments. *, p<0.05 compare to control (one-way 
ANOVA with Scheffe’s test). 
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Figure 5   Effects of Akt on cell growth regulatory proteins. The C141 cells were 
pretreated with different concentrations of LY294002, wortmanin for 30 
min before vanadate treatment (50 µM for 24 h). Western blotting was 
performed to examine the protein levels of cyclin E, cyclin A, E2F1 and 
phosphorylation of Rb. Lane 1, control; lane 2, vanadate; lane 3, vanadate + 
10 µM LY; lane 4, vanadate + 20 µM LY; lane 5, vanadate + 50 nM 
wortmanin; and lane 6, vanadate + 100 nM wortmanin. Data are from a 
single preparation representative of three independent experiments. 
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Figure 5   Effects of Akt on cell growth regulatory proteins. The DN/K cells and DN/P 
cells were treated with 50 µM vanadate for different time. Western blotting 
was performed to examine the protein levels of cyclin E, cyclin A, E2F1 and 
phosphorylation of Rb. Left part and right part represent DN/K cells and 
DN/P cells, respectively. Lanes 1 and 6, control; lanes 2 and 7, 50 µM 6 h; 
lanes 3 and 8, 50 µM, 12 h; lanes 4 and 9, 50 µM, 24 h; and lanes 5 and 10, 
50 µM, 48 h. Data are from a single preparation representative of three 
independent experiments. 
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Figure 5   Effects of Akt on cell growth regulatory proteins. The DN/K cells and DN/P 
cells were treated with different doses of vanadate for 24 h. Western blotting 
was performed to examine the protein levels of cyclin E, cyclin A, E2F1 and 
phosphorylation of Rb. Left part and right part represent DN/K cells and 
DN/P cells, respectively. Lanes 1 and 6, control; lanes 2 and 7, 10 µM 24 h; 
lanes 3 and 8, 25 µM, 24 h; lanes 4 and 9, 50 µM, 24 h; and lanes 5 and 10, 
100 µM, 24 h. Data are from a single preparation representative of three 
independent experiments. 
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Figure 6   Effects of PI3K on Akt activity. The C141 cells were seeded in 100 mm dishes. 
After 80% confluence, the cells were pre-treated with different concentrations 
of LY294002, and wortmanin before vanadate treatment (50 µM). Panel A: 
lane 1, control without vanadate stimulation, 60 min; lane 2, vanadate 60 min; 
lane 3, vanadate + 10 µM LY, 60 min; lane 4, vanadate + 20 µM LY, 60 min; 
lane 5, vanadate + 50 nM wortmanin, 60 min; and lane 6, vanadate + 100 nM 
wortmanin, 60 min. Panel B: lanes 1 and 7, control; lane 2, 50 µM 15 min; lane 
3, 50 µM, 30 min; lanes 4, 50 µM, 60 min; lanes 5 and 10, 50 µM, 120 min; 
lane 6, 50 µM, 240 min; lane 8, 10 µM, 120 min; lane 9, 25 µM, 120 min; and 
lane 11, 100 µM, 120 min. Data are from a single preparation representative of 
three independent experiments. 
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Figure 7   Effects of PI3K on Akt phosphorylation. The C141 cells were spread in 100 
mm dishes. After 80% confluence, the cells were pre-treated with different 
concentrations of LY294002, and wortmanin prior to vanadate treatment (50 
µM). Western blotting was used for measurement of Akt phosphorylation. 
Lane 1, control without vanadate stimulation, 120 min; lane 2, vanadate 120 
min; lane 3, vanadate + 10 µM LY, 120 min; lane 4, vanadate + 20 µM LY, 
120 min; lane 5, vanadate + 50 nM wortmanin, 120 min; and lane 6, vanadate 
+ 100 nM wortmanin, 120 min. Data are from a single preparation 
representative of three independent experiments. 
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Figure 7   Effects of PI3K on Akt phosphorylation. The DN/K cells and DN/P cells were 
treated with 50 µM vanadate for different time. Western blotting was used for 
measurement of Akt phosphorylation. Left part and right part represent DN/K 
cells and DN/P cells, respectively. Lanes 1 and 7, control; lanes 2 and 8, 50 µM 
15 min; lanes 3 and 9, 50 µM, 30 min; lanes 4 and 10, 50 µM, 60 min; lanes 5 
and 11, 50 µM, 120 min; and lanes 6 and 12, 50 µM, 240 min. Data are from a 
single preparation representative of three independent experiments. 
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Figure7   Effects of PI3K on Akt phosphorylation. The DN/K cells and DN/P cells were 
treated with different doses of vanadate for 24 h. Western blotting was used for 
measurement of Akt phosphorylation. Left part and right part represent DN/K 
cells and DN/P cells, respectively. Lanes 1 and 6, control; lanes 2 and 7, 10 
µM, 120 min; lanes 3 and 8, 25 µM, 120 min; lanes 4 and 9, 50 µM, 120 min; 
and lanes 5 and 10, 100 µM, 120 min. Data are from a single preparation 
representative of three independent experiments. 
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SECTION VI 
 
 
The Role of Phosphatidylinositol-3 Kinase and p70 S6 Kinase in 
Vanadate-induced Cell Cycle Arrest at S Phase 
181
VI.1. ABSTRACT 
 
Phosphatidylinositil-3 kinase (PI3K) is a heterodimer of catalytic and regulatory 
subunits. It is involved in various signaling pathways and key functions of the cells. The 
present study investigated the role of PI3K in vanadate-induced cell cycle arrest in C141 
mouse epidermal cells. Vanadate caused a dose-dependent increase in p21 and decrease 
in both cdc25A and cdk2. In stable transfaction with dominant negative p85 luciferase 
reporter ∆p85 cells, vanadate did not alter these cell cycle regulatory proteins. Vanadate 
caused a time- and dose-dependent increase in PI3K activity through phosphorylation of 
p70 S6 kinase (p70S6K) at Thr421/Ser424 and Thr389 sites. The phosphorylation at 
these sites was inhibited both by PI3K inhibitor, LY294002, and p70S6K mutation. 
Moreover, vanadate induced S phase arrest was inhibited by LY294002 and rapmycin, a 
p70S6K inhibitor. Vanadate-induced S phase arrest was also inhibited in transfection 
with dorminant negeative p70S6K mutant cells. In these cells, vanadate-induced 
activation of p21 and the degradation of cdc25A and cdk2 were inhibited. Taken together 
the results obtained show that vanadate is able to increase PI3K activity through 
phosphorylation. PI3K activated p70S6K, which phosphated protein S6 and controlled 
the cell cycle regulatory proteins and blocked vanadate-induced cell cycle arrest at S 
phase. 
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VI.2. INTRODUCTION 
 
Epidemiological studies have demonstrated that inhalation of environmental or 
occupational airborne particle mattes results in an increased incidence of 
cardiopulmonary disorders and lung cancer (1-4). Yet our understanding about biological 
mechanisms and the initiation and progression of disease as a result of exposure to 
particular mattes is still primitive and fragmentary. Most of environmental and 
occupational particular matters contain various trace metal ions, including vanadium, 
chromium, arsenite, zinc, and nickel (5,6). It is generally believed that metal ions may 
contribute to the pathological effects of inhaled particular matters. Among these metal 
ions, vanadate regulates growth factors mediated by signal transduction, promotes cell 
transformation, and decreases cell adhesion (7-10). Vanadate-containing compounds 
exert potent toxic effects on a wide variety of biological systems (7,11). Vanadium 
compounds were reported to modify DNA synthesis (12), cause direst DNA damage and 
induce DNA strand breaks (13). Epidemiological studies have shown a correlation 
between vanadium exposure and the incidence of lung cancer in humans (14,15). 
 
The regulation of cell cycle is frequently altered in human cancer cells (16). Cells 
initiate apoptosis and cell cycle arrest checkpoints in resonse to DNA-damaging agents, 
such as γ irradiation (17). This is biologically important since the failure of DNA-
damaged cells to die or growth arrest allows the accumulation of new mutations and may 
contribute to tumorigenic development (18). Thus apoptosis and cell growth arrest are 
biological defense against DNA damage to maintain genomic integrity. Our recent 
studies have shown that vanadate caused cell cycle arrest at S phase and mitogen-
activated proteins kinses (MAPKs) were involved (19-21). In the present study, we 
investigated the mechanistic aspect of vanadate-induced cell cycle arrest at S phase with 
focus on the role of phosphatidylinositol-3 kinase (PI3K). PI3K is a hetrodimer of 
catalytic and regulatory subunits with molecular weights of 110 KD (p110) and 85 KD 
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(p85), respectively. It is an enzyme that participates in a variety of cellular processes and 
whose activity has liked to cell growth and transformation, differentiation, motility, 
insulin action, and cell survival (22,23). Direct links between PI3K and human diseases 
have been made, most notably in cancer (23). Recent studies have suggested that the 
involvement of PI3K in regulating cell division may be through at least two mechanisms: 
the PI3K lipid kinase activity and direct interaction of PI3K with some cellular signal 
proteins (22). We hypothesize that vanadate may induce activation of PI3K, which up-
regulates its downstream, p70S6K, affects cell growth regulatory proteins, p21, cdc25A 
and cdk2, and induces cell cycle arrest. The present study will test this hypothesis. 
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VI.3. MATERIALS AND METHODS 
 
Chemicals   Sodium metavanadate was purchased from Aldrich (Milwaukee, WI). 
RNase A and Eagle’s minimal essential medium (MEM) were from Sigma (St. Louis, 
MO) were from Sigma (St. Louis, MO). Propidium iodide (PI) was from Molecular 
Probes (Eugene, OR). Fetal bovine serum (FBS) was from Gibco BRL (Life 
Technologies, Gaithersburg, MD). LY294002 and rapamycin were from Calbiochem 
(San Diego, CA). Antibodies to p21 and cdc25A were from Santa Cruz Biotechnology 
(Santa Cruz, CA). Antibodies to phospho-cdk2 at Thr160, p70S6K and second AP linked 
anti-rabbit IgG were from Cell Signaling (Beverly, MA). 
 
Cell culture   The JB6 P+ mouse epidermal cell line, C141 cells, and its stable 
transfection with dominant negative p85 luciferase reporter cells, ∆p85 cells, and its 
stable transfection with dominant negative mutant p70S6 kinase cells (DN/p70S6K) were 
cultured in MEM medium containing 5% FBS, 2 mM L-glutamine and 1000 U/ml 
penicillin-streptomycin in an incubator at 5% CO2 and 37°C. 
 
Measurement of cell cycle/DNA content   DNA content in G1/S, G2/M phase was 
detected using flow cytometry (24,25). Both C141 cells and DN/p70S6K cells were fixed 
and permeabilized with 70% ice-cold ethanol for more than 2 h, and incubated with the 
freshly prepared staining buffer (0.1% Triton X-100 in PBS, 200 µg/ml RNase A, and 20 
µg/ml PI) for 15 min at 37°C.  Cell cycle analysis was performed by flow cytometry with 
at least 10,000 cells for each sample.  The histogram was abstracted and the percentages 
of cells in the G1/S and G2/M phase were then calculated using ModFit LT software. 
 
Western blotting analysis   The cells were seeded in 100mm dishes. Cells were 
lysed in RIPA buffer (150 mM NaCl, 100 mM Tris (pH 8.0), 1% Triton X-100, 1% 
deoxycholic acid, 0.1% SDS, 5 mM EDTA and 10 mM NaF) supplemented with 1 mM 
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sodium vanadate, 2 mM leupeptin, 2 mM aprotinin, 1 mM phenylmethylsulfonyl fluoride 
(PMSF), 1 mM DTT, and 2 mM pepstatin A on ice for 30 min.  After centrifugation at 
14,000 rpm for 5 min, the supernatant was harvested as the protein extract.  The protein 
concentration was determined using Bio-Rad protein assay reagent (Richmond, CA).  
The protein extracts were run by Tris-Glycine SDS gel electrophoresis, and transferred to 
PVDF membrane. Western blotting was performed using antibodies against p21, cdc25A, 
phospho-cdk2Thr160, p70S6K and second anti-rabbit IgG. After reaction with ECF 
substrate, the signal was detected using a Storm Scanner (Molecular Dynamics, 
Sunnyvale, CA). 
 
PI3K activity assay   Cells were washed with ice-cold PBS and scraped from the 
plates, and centrifuged at 4,000 rpm for 5 min.  The cell pellet was incubated for 20 min 
on ice in lysis buffer (150 mM NaCl, 100 mM Tris-HCl (pH 8.0), 1% Triton X-100, 5 
mM EDTA, 10 mM NaF) supplemented with 1 mM DTT, 1 mM PMSF, 1 mM sodium 
vanadate, 2 mM leupeptin, and 2 mM aprotinin, and centrifuged at 11,000 rpm for 15 min 
to clarify the supernatants. PI3K activity was analyzed using 400 µg of protein extracts 
and anti-p110 antibodies as described (28, 29). Briefly, 400 µg of total protein was 
incubated 20 µl of protein A/G plus agarose for 1 h at 4°C on a rotator, followed by 
spinning at 3,000 rpm for 3 min. The supernatant was then incubated with 10 µl of p110-
PI3 kinase antibody for 1 h at 4°C. 30 µl of protein A/G agarose beads were added for an 
additional 1 h. The beads were then pelleted and washed sequentially with TNE buffer 
(containing 20 mM Tris, pH7.5, 100 mM NaCl and 1 mM EDTA) for five times; and 
once with 20 mM HEPES. PI3K assays were performed using phosphatidylinositol as 
substrate in a final volume of 50 µl containing 20 mM HEPES (pH 7.5), 10 mM MgCl, 2 
µCi [γ-32P] ATP, 60 µM ATP, and 0.2 mg/ml sonicated phosphatidylinositol. Reactions 
were carried out for 15 min at room temperature and extracted by the addition of 80 µl 
1M HCl and 160 µl chloroform/methanol (1:1).  After centrifugation, organic phase was 
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evaporated to dryness and separated by Thin Layer Chromatographer (TLC).  
Phosphorylated lipids were identified by autoradiography. 
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VI.4. RESULTS 
 
Effects of the vanadate on p21, cdc25A and phoshpo-cdk2Thr160 in both C141 cells 
and ∆p85 cells The previous studies showed that vanadate is able to cause cell cycle 
arrest at S phase. Here several S phase regulatory proteins were examined in vanadate-
stimulated C141 cells. Western blotting was used to measure the expression of both p21 
and cdc25A, and phosphorylation of cdk2 (Figure 1). In C141 cells, vanadate caused 
expression of p21 and degradation of cdc25A (panel A). Treatment of the cells with 50 
µM vanadate for 6 h decreased phosphorylation of cdk2. At 24 h and 48 h treatment,  
phospho-cdk2 was almost abolished (panel A, lanes 4 and 5). A dose-dependent 
inactivation of phospho-cdk2 was observed when the cells were treated with different 
times (panel A, lanes 6 to 10). In contrast, in ∆p85 cells vanadate could not alter the 
expression of p21 and cdc25A, or phosphorylation of cdk2 regardless treatment times and 
doses (panel B). 
 
Effects of vanadate on PI3K activity and cell cycle regulatory proteins in C141 
cells   In the present study, thin layer chromatographer was used to examine PI3K 
activity, and Western blotting was performed to measure the cell growth regulatory 
proteins. As shown in Figure 2, panel A a, in C141 cells treatment with 50 µM vanadate 
increased the signal intensity from 15 min to 240 min compared to the control. A dose-
dependency was also observed when the C141 cells were treated with different 
concentrations of vanadate (panel A, b). In panel B, addition of LY294002, an inhibitor of 
PI3K, decreased p21 expression induced by vanadate, and increased phosphorylation of 
cdk2 inactivated by vanadate. 
 
Effects of vanadate on p70S6K in both C141 cells and ∆p85 cells Western 
blotting was used to detect the phosphorylation of p70S6K in C141 cells, vanadate caused 
phosphorylation of p70S6K at both Thr421/Ser424 and Thr389 in a time- and dose-
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dependent manner (Figure 3, panel A). In ∆p85 cells, vanadate treatment failed to cause 
phosphorylation at these sites (Figure 3, panel B). 
 
Effects of PI3K on vanadate-induced p70S6K phosphorylation   p70S6K is a 
downstream target kinase of PI3K. In the previous two sections, we have shown that 
vanadate is able to activate both PI3K and p70S6K. In this section, PI3K inhibitor, 
LY924002, was used to evaluate the role of PI3K in vanadate-induced p70S6K 
phosphorylation. As shown in Figure 4, the presence of LY294002 completely prevented 
PI3K activation in vanadate-treated C141 cells (panel A). Such inhibition subsequently 
affected the downstream protein p70S6K phosphorylation. LY294002 completely 
inhibited p70S6K phosphorylation at Thr421/Ser424 and Thr389 (panel B). In 
DN/p70S6K cells, phosphorylation at Thr421/Ser424 and Thr389 sites did not occur 
regardless vanadate treatment times and doses (panel C). 
 
Effects of PI3K on vanadate-induced cell cycle arrest   As shown in Figure 5, 
panel A, LY294002 inhibited vanadate-induced S phase arrest in C141 cells. Similar 
effect was also observed in the cells treated with p70S6K inhibitor, rapmycin. Moreover, 
in the DN/p70S6K cells, although vanadate treatment caused increase in S phase, it was 
much less potent (Panels B and C). For comparison, data of vanadate-induced S phase 
arrest in wild type C141 cells were provided in Figure 5, panels D and E. 
 
Effects of PI3K on cell growth regulatory proteins in vanadate-treated cells   In 
the previous section, we have shown that vanadate induced an increase in p21 and 
decreased in cdc25A and phosphated cdk2 through action of PI3K. In this section, we 
examined the role of p70S6K. In contrast with wild type C141 cells (Figure 1A), vanadate 
decreased p21 and it did not decrease cdc25A or phosphated cdk2. Instead, in the 
DN/p70S6K cells, vanadate increased the levels of cdc25A and phosphated cdk2. These 
results are opposite to those observed using wild type C141 cells, demonstrating the role 
of p70S6K in vanadate-induced alternation of those cell cycle regulatory proteins. 
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VI.5. DISCUSSION 
 
The ability of cells to maintain genomic integrity is vital for cell survival and 
proliferation. Cell cycle transitions are controlled by distinct families of cyclin-dependent 
kinases (cdks). The activity of these kinases is regulated by association with cyclins and 
cdk inhibitors and by positive and negative phosphorylation (26-28). Following 
association with cyclins and positive phosphorylation at a specific threonine residue, cdks 
are maintained in an inactive state by inhibitory phosphorylation at Thr14 and Tyr15 
(22,26). The inactive cyclin/cdk complexes are dephosphorylated by cdc25 phophatases, 
which are regard as important regulators of cell progression (29). Among the three cdc25 
isoforms, cdc25A promotes entry of cells into S phase by dephosphorylating and 
activating cdk2/cyclin E and cdk2/cyclinA complexes (30). An inhibitory protein, p21, 
exhibits its cell growth inhibiting activity through its interaction with cdk2. In the present 
study, we have shown that in wild type C141 cells under vanadate stimulation, p21 
protein level was increased while cdc25A level and phosphorylation of cdk2 were 
decreased. Since cdc25A and cdk2 promote G1/S phase progression and p21 inhibits it, 
the results were consistent with our previous report that vanadate was able to cause S 
phase arrest (19). The question is how these cell cycle regulatory proteins are regulated. 
In the present study, we examined the role of PI3K and its downstream target proteins. In 
C141 cells with dominant negative mutant of the regulatory subunit of PI3K, ∆p85 cells, 
vanadate did not cause any observable change in p21, cdc25A or cdk2. These results 
demonstrate that PI3K is required for vanadate-induced alteration in these cell cycle 
regulatory proteins. 
 
Using thin layer chromatographer, we have shown that vanadate increased PI3K 
activity. One of the important downstream targets of PI3K is p70S6K. The importance of 
this kinase at a molecular level is that it is involved in the selective translational 
regulation of a unique family of mRNAs, by mediating the multiple phosphorylation of 
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40S ribosomal protein S6 (31). These mRNAs encode for components of the translational 
apparatus, including ribosomal proteins and translational elongation factors whose 
increased expression is essential for cell growth and proliferation (32). In the present 
study, we have measured vanadate-induced phosphorylation of p70S6K at Thr421/Ser424 
and Thr389 sites. In ∆p85 cells, the phosphorylation at these sites was not observed, 
indicating an important role of PI3K in p70S6K phosphorylation. We have also examined 
the role of PI3K in vanadate induced p70S6K phosphorylation using PI3K inhibitor, 
LY294002. This inhibitor decreased vanadate-induced PI3K activation. LY294002 
inhibited vanadate-induced phosphorylation of p70S6K at Thr421/Ser424 and Thr389. In 
DN/p70S6K cells, vanadate failed to phosphorylate p70S6K. The above results indicated 
that vanadate induced PI3K activation, which then caused p70S6K phosphorylation. 
 
Using flow cytometry to measure DNA content, our results show that vanadate is 
able to induce cell cycle arrest at S phase in wild type C141 cell. PI3K inhibitor, 
LY924002, and p70S6K inhibitor, rapmycin, blocked vanadate-induced cell cycle arrest 
at S phase. In DN/p70S6K cells, vanadate-induced cell cycle arrest at S phase was 
inhibited. These results show that PI3K and p70S6K were involved in the mechanism of 
vanadate-induced cell cycle arrest. The relationship between cell cycle regulatory 
preotiens and p70S6K was also investigated in the present study. The results showed that 
in DN/p70S6K cells, vanadate-induced activation of p21 and degradation of cdc25A and 
cdk2 were inhibited. These results are consistent with inhibition of vanadate-induced cell 
cycle arrest at S phase. Now the question is how PI3K and p70S6K affect the cellular 
regulatory proteins. Phosphoyrlated S6 kinase increases production of the translational 
mechanery such as ribosomal proteins and alongation factors. PI3K also appears to play a 
role in the down-regulation of the cdk inhibitors p27 and p21 (33). p21 may be a direct 
target of Akt phosphorylation. PI3K and its downstream kinase Akt are signaling 
intermediates that link cell surface receptors to p70S6K (23). The previous chapter of this 
dissertation has shown that vanadate was able to increase Akt kinase activity and cause 
phosphorylation at Ser473 and Thr308. Akt-mediated phosphorylation of p21 was shown 
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to cause its translocation from nucleus, thus preventing its inhibition of nuclear cdks (34). 
Evidence is now accumulating that PI3K signals are required together with ERK 
signaling for transcriptional induction of cyclin D1. This cyclin is necessary for cdk 
activation and for G1 progression (35). In our previous study, we have also shown that 
MAPKs are important mediators in vanadate-induced cell cycle arrest at S phase (20). 
While it appears that PI3K, p70S6K, Akt and MAPKs maybe all directly or indirectly 
involved in the regulation cell cycle regulatory proteins, p21, cdc25A and cdk2, the 
mechanisms of actions remain to be investigated. 
 
In conclusion, the results obtained from the present study show that vanadate 
induced PI3K activation, which phosphated p70S6K. The activated p70S6K triggered its 
downstream protein, 40S ribosomal protein S6, leading to activation of p21, decrease in 
cell cycle regulatory proteins, cdc25A and cdk2 and caused cell cycle arrest at S phase. 
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VI.6. FIGURES 
 
 
 
 
Figure 1   Effects of vanadate on cell growth regulatory proteins in both C141 cells and 
∆p85 cells. C141cells were treated with 50 µM vanadate for 6, 12, 24 and 48 
h and 10, 25, 50, 100 µM for 24 h. The whole cell lysates were collected for 
Western blotting using specific antibodies aganist p21, cdc25A and p-cdk2 
and p21. Lanes 1 and 6, control; lane 2, 50 µM, 6 h; lane 3, 50 µM, 12 h; 
lanes 4 and 9, 50 µM, 24 h; lane 5, 50 µM, 48 h; lane 7, 10 µM, 24 h; lane 8, 
25 µM, 24 h; and lane 10, 100 µM, 24 h. Data from a single preparation 
representative of three independent experiments. 
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Figure 1   Effects of vanadate on cell growth regulatory proteins in both C141 cells and 
∆p85 cells. ∆p85 cells were treated with 50 µM vanadate for 6, 12, 24 and 48 
h and 10, 25, 50, 100 µM for 24 h. The whole cell lysates were collected for 
Western blotting using specific antibodies aganist p21, cdc25A and p-cdk2 
and p21. Lanes 1 and 6, control; lane 2, 50 µM, 6 h; lane 3, 50 µM, 12 h; 
lanes 4 and 9, 50 µM, 24 h; lane 5, 50 µM, 48 h; lane 7, 10 µM, 24 h; lane 8, 
25 µM, 24 h; and lane 10, 100 µM, 24 h. Data from a single preparation 
representative of three independent experiments. 
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Figure 2   Effects of vanadate on PI3K activity and cell cycle regulatory proteins in C141 
cells. The cells were treated with 50 µM vanadate from 0 to 240 min and 10, 
25, 50, 100 µM for 60 min. The whole cell lysates were used to measure PI3K 
activity. Lanes 1 and 7, control; lane 2, 50 µM, 15 min; lane 3, 50 µM, 30 
min; lanes 4 and 10, 50 µM, 60 min; lane 5, 50 µM, 120 min; lane 6, 50 µM, 
240 min; lane 7, 10 µM, 60 min; lane 8, 25 µM, 60 min; and lane 10, 100 µM, 
60 min. Data from a single preparation representative of three independent 
experiments. 
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Figure 2   Effects of vanadate on PI3K activity and cell cycle regulatory proteins in C141 
cells. The cells were pretreated with LY294002 for 30 min followed by 50 µM 
vanadate stimulation for 24 h. The whole cell lysates were collected for 
Western blotting. Lanes 1, control; lane 2, 50 µM vanadate; lane 3, 50 µM 
vanadate + 10 µM LY; and lane 4, 50 µM vanadate + 20 µM LY. Data from a 
single preparation representative of three independent experiments. 
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Figure 3   Effects of vanadate on p70S6K in both C141 cells and ∆p85 cells. C141 cells 
were treated with 50 µM vanadate from 0 to 24 h and 10, 25, 50, 100 µM for 
12 h. Western blotting was used for measurement of phosphorylation of 
p70S6K. Lanes 1 and 7, control; lane 2, 50 µM, 3 h; lane 3, 50 µM, 6 h; lanes 
4 and 9, 50 µM, 12 h; lanes 5, 50 µM, 24 h; lane 7, 10 µM, 12 h; lane 8, 25 
µM, 12 h; and lane 10, 100 µM, 12 h. Data from a single preparation 
representative of three independent experiments. 
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Figure 3   Effects of vanadate on p70S6K in both C141 cells and ∆p85 cells. ∆p85  cells 
were treated with 50 µM vanadate from 0 to 24 h and 10, 25, 50, 100 µM for 
12 h. Western blotting was used for measurement of phosphorylation of 
p70S6K. Lanes 1 and 7, control; lane 2, 50 µM, 3 h; lane 3, 50 µM, 6 h; lanes 
4 and 9, 50 µM, 12 h; lanes 5, 50 µM, 24 h; lane 7, 10 µM, 12 h; lane 8, 25 
µM, 12 h; and lane 10, 100 µM, 12 h. Data from a single preparation 
representative of three independent experiments. 
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Figure 4   Effects of PI3K on p70S6K in C141 cells and in DN/p70S6K cells. The C141 
cells were seeded in 6-well plates. After 80% confluence, the cells were pre-
treated with different concentrations of LY294002 before vanadate treatment 
(50 µM). Kinase assay was used to detect PI3K activity. Lane 1, control 
without vanadate stimulation, 60 min; lane 2, vanadate 60 min; lane 3, 
vanadate + 10 µM LY, 60 min; and lane 4, vanadate + 20 µM LY, 60 min. 
Data from a single preparation representative of three independent 
experiments. 
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Figure 4   Effects of PI3K on p70S6K in C141 cells and in DN/p70S6K cells. The C141 
cells were seeded in 6-well plates. After 80% confluence, the cells were pre-
treated with different concentrations of LY294002 before vanadate treatment 
(50 µM). Western blotting was analyzed for measurement of p70S6K 
phosphorylation. Lane 1, control without vanadate stimulation; lane 2, 
vanadate; lane 3, vanadate + 10 µM LY; and lane 4, vanadate + 20 µM LY. 
Data from a single preparation representative of three independent 
experiments. 
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Figure 4   Effects of PI3K on p70S6K in C141 cells and in DN/p70S6K cells. The 
DN/p70S6K cells were seeded in 6-well plates. After 80% confluence, the 
cells were treated with vanadate for different doses and times. Western 
blotting analysis was used for measurement of p70S6K phosphorylations. 
Lanes 1 and 6, control; lane 2, 50 µM, 3 h; lane 3, 50 µM, 6 h; lanes 4 and 9, 
50 µM, 12 h; lanes 5, 50 µM, 24 h; lane 7, 10 µM, 12 h; lane 8, 25 µM, 12 h; 
and lane 10, 100 µM, 12 h. Data from a single preparation representative of 
three independent experiments. 
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Figure 5   Effects of both PI3K and p70S6K on cell cycle arrest. The C141 cells were 
pretreated with different concentrations of LY294002 and rapmycin for 30 min 
before vanadate treatment (50 µM, 24 h). DNA content was used to measure 
the percentage of the cells at S phase. a, control without stimulation; b, 50 µM 
vanadate; c, 50 µM vanadate + 10 µM LY; d, 50 µM vanadate + 20 µM LY; e, 
50 µM vanadate + 10 µM rapmycin; and f, 50 µM vanadate + 20 µM 
rapmycin. Data from a single preparation representative of three independent 
experiments. 
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Figure 5   Effects of both PI3K and p70S6K on cell cycle arrest. DN/p70S6K cells were 
treated with 50 µM vanadate for different time (6, 12, 24, and 48 h). DNA 
content was used to measure the percentage of the cells at S phase. a, control; 
b, 6h; c, 12h; d, 24h; and e, 48h. Data from a single preparation representative 
of three independent experiments. 
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Figure 5   Effects of both PI3K and p70S6K on cell cycle arrest. DN/p70S6K cells were 
treated with different doses of vanadate (10, 25, 50, and 100 µM) for 24 h. 
DNA content was used to measure the percentage of the cells at S phase. a, 
control; b, 10 µM; c, 25 µM; d, 50 µM; and e, 100 µM. Data from a single 
preparation representative of three independent experiments. 
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Figure 5   Effects of both PI3K and p70S6K on cell cycle arrest. C141 cells were treated 
with different time (6, 12, 24, and 48 h). DNA content was used to measure the 
percentage of the cells at S phase. a, control; b, 6 h; c, 12 h; d, 24 h; and e, 48 
h. Data from a single preparation representative of three independent 
experiments. 
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Figure 5   Effects of both PI3K and p70S6K on cell cycle arrest. C141 cells were treated 
with different doses of vanadate for 24 h. DNA content was used to measure 
the percentage of the cells at S phase. a, control; b, 10 µM; c, 25 µM; d, 50 
µM; and e, 100 µM. Data from a single preparation representative of three 
independent experiments. 
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Figure 6   Role of p70S6K on cell cycle regulatory proteins. The DN/p70S6K cells were 
pretreated with vanadate at different time and doses. Western blotting was 
performed to examine the protein level of p-cdk2 and p21. Lanes 1 and 6, 
control; lanes 2, 50 µM 6 h; lane 3, 50 µM, 12 h; lanes 4 and 9, 50 µM, 24 h; 
lane 5, 50 µM, 48 h; lane 7, 10 µM, 24 h; lane 8, 25 µM, 24 h; and lane 10, 100 
µM, 24 h. Data from a single preparation representative of three independent 
experiments. 
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OVERALL CONCLUSIONS 
 
1. Vanadate is able to cause the generation of ROS, which up-regulate ERK and 
p38. These MAPK members regulate cell growth regulatory proteins, cdc25C and 
p21, leading to cell cycle arrest at G2/M phase. 
 
2. Vanadate is capable of inducing S phase arrest, and this interruption of cell cycle 
progression is p53-dependent. Activation of p53 leads to an increase in p21 
expression, resulting in a pause in growth progression at S phase. 
 
3. Vanadate causes activation of both ERK and p38, and p53. Vanadate-induced S 
phase arrest is mediated by MAPKs through p53-dependent pathway. 
 
4. The dependency of p53 is both cell type- and phase-specific. Vanadate is able to 
induce p53-independent G2/M phase arrest, and cdc25C, but not p21, is 
responsible for this type of arrest. 
 
5. Vanadate increased Akt kinase activity and caused its phosphorylation. The 
activation of Akt affected on the E2F1/pRb complex, leading to the transition of 
G1 to S phase. PI3K/Akt plays an essential role in vanadate-induced S phase arrest 
through E2F1-pRb pathway. 
 
6. Vanadate induced PI3K activation, which phosphated p70S6K at Thr421/Ser424 
and Thr389 sites. The activated p70S6K triggered its downstream protein, 40S 
ribosomal protein S6, leading to activation of p21 and decrease in cell cycle 
regulatory proteins, resulting in cell cycle arrest at S phase. 
212
CURRICULUM VITAE 
 
 
Education  
1999  present School of Pharmacy, West Virginia University, Ph. D. degree 
candidate 
1990  1993 Zhejiang Medical University, MPH, Hangzhou, Zhejiang, P. R. 
China 
1985  1990 Fujian Medical College, MD, Fuzhou, Fujian, P. R. China 
 
Work Experience 
1998  1999 Chinese Medical Board (CMB) Advanced Fellowship in 
Occupational and Environmental Health, Dept. of Community, 
Occupational and Family Medicine, National University of 
Singapore, Singapore 
1996  1998 Lecturer, Dept. of Pneumoconiosis, Medical School of Zhejiang 
University, P. R. China 
1993  1996 Teaching and Research Assistant, Zhejiang Medical University, P. 
R. China 
 
Awards and Honors 
1999 Excellent presentation award in National Conference of Prevention 
Pneumoconiosis, PR China 
1996 The Third Prize for Progression on Science and Technology by Zhejiang 
Province, PR China 
1994 Excellent thesis award in Natural Sciences in ZHejiang Province, PR China 
 
 
 
213
Publications 
1. Zhang Z, Gao N, Huang C, Chen F, He H, Shi X. Invovlement of E2F1-pRb in 
vanadate-induced S phase arrest through Akt pahtway. In preparation 
2. Zhang Z, Gao N, Huang C, Chen F, He H, Vallyathan V, Shi X. The role of 
phosphatidylinositol-3 kinase and p70 S6 kinase in vanadate-induced S phase 
arrest. In preparation 
3. Zhang Z, Leonard SS, Qian Y, Chen F, Huang C, Vallyathan V, Catranova V, 
Shi X. Vanadate induces cell growth arrest through MAPKs and reactive oxygen 
species. In preparation 
4. Gao N, Flynn DC, Zhang Z, Chen B, Walker V, Lin J, Liu K, Shi X, Jiang B. 
The G1 cell cycle progression and the expression of G1 cyclins are regulated by 
PI3K/AKT/mTOR signaling in human ovarian cancer cells. In preparation 
5. Gao N, Jiang B, Leonard SS, Corum L, Zhang Z, Boberts J, Antonini J, Zheng J, 
Flynn D, Shi X. Chromium (VI) induced expression of hypoxia-inducible factor 1 
and vascular endothelial growth factor in DU145 human prostate carcinoma cells 
through reactive oxygen species. In preparation 
6. Gao N, Ding M, Zheng J, Zhang Z, Leonard SS, Liu K, Shi X, Jiang B. Vanadate 
induced expression of hypoxia-inducible factor 1 and vascular endothelial growth 
factor through phosphatidylinositol 3-kinase/Akt pathway and reactive oxygen 
species. In preparation 
7. Zhang Z, He H, Chen F, Huang C, Shi X. MAPKs mediate S phase arrest 
induced by vanadate through a p53 dependent pathway in mouse epidermal JB6 
cells. Chem. Res. Toxicol. In press 
8. Zhang Z, Chen F, Huang C, Shi X. Vanadate induces G2/M phase arrest in p53 
deficient mouse embryo fibroblasts. J Environ Pathol Toxicol Oncol. In press 
 
9. Zhang Z, Huang C, Li J, Shi X. Vanadate-induced cell growth arrest is p53-
dependent through activation of p21 in C141 Cells. J. Inorg. Biochem. 89:142-8, 
2002 
214
10. Chen F, Zhang Z, Bower J, Lu Y, Leonard SS, Ding M, Castranova C, Piwnica-
Worms H, Shi X. Arsenite-induced Cdc25C degradation is through the KEN-box 
and ubiquitin-proteasome pathway. Proc. Natl. Acad. Sci. 99(4): 1990-5, 2002 
11. Huang C, Li J, Costa M, Zhang Z, Leonard SS, Castranova V, Vallyathan V, Ju 
G, Shi X. Hydrogen peroxide mediates activation of nuclear factor of activated T 
cells (NFAT) by nickel subsulfide. Cancer Res. 61 (22): 8051-7, 2001 
12. Zhang Z, Leonard SS, Wang S, Vallyathan V, Castranova V, Shi X. Cr (VI) 
induces cell growth arrest through hydrogen peroxide-mediated reaction. Mol. 
Cell. Biochem. 222 (1-2): 77-83, 2001 
13. Zhang Z, Huang C, Li J, Leonard SS, Lanciott R, Butterworth L, Shi X. 
Vanadate-induced cell growth regulation and the role of reactive oxygen species. 
Arch. Biochem. Biophy. 392 (2): 311-20, 2001 
14. Qian Y, Jiang B, Leonard SS, Wang S, Zhang Z, Ye J, Chen F, Wang L, Shi X, 
Flynn DC. Cr (VI) increases tyrosine phosphorylation through reactive oxygen 
species-mediated reactions. Mol. Cell. Biochem. 222 (1-2): 199-204, 2001 
15. Liu K, Husler J, Ye J, Culter D, Leonard SS, Chen F, Wang S, Zhang Z, Wang L, 
Shi X. On the mechanism of Cr (VI)-induced carcinogenesis: dose dependence of 
cellular responses. Mol. Cell. Biochem. 222 (1-2): 221-9, 2001 
16. Chen F, Zhang Z, Leonard SS, Shi X. Constrasting roles of NF-κB and JNK in 
arsenite-induced p53-independnet expression of GADD45α. Oncogene 20: 3585-
3589, 2001 
17. Chen F, Lu Y, Zhang Z, Vallyathan V, Ding M, Castranova C, Shi X. Opposite 
effect of NF-κB and c-jun-N-terminal kinase on p53-independent GADD45 
induction by arsenite. J. Biol. Chem. 276 (14): 11414-11419, 2001 
18. Shen H, Zhang Z, Zhang Q, Ong C. Reactive oxygen species and caspase 
activation mediated silica-induced apoptosis in alveolar macrophages. Am. J. 
Physiol. 280: L10-17, 2001 
215
19. Huang C, Zhang Z, Ding M, Li J, Leonard SS, Shen H, Lu Y, Castranova V, 
Vallyathan V, Shi X. Vanadate (V)-induced apoptosis through hydrogen 
peroxide-mediated p53-dependent pathway. J. Biol. Chem. 275: 32516-22, 2000 
20. Zhang Z, Shen H, Zhang Q, Ong C. Involvement of oxidative stress in silica-
induced cytotoxicity and genotoxicity in alveolar macrophages. Environ. Res. 82: 
245-252, 2000 
21. Zhang Z, Shen H, Zhang Q, Ong C. Critical role of glutathione in silica-induced 
oxidative stress, cytotoxicity and genotoxicity in alveolar macrophages. Am. J. 
Physiol. 277: L743-48, 1999 
 
Abstract, Posters and Presentations 
Vanadate induces cell growth arrest through MAP kinase and ROS. Zhang Z, 
Leonard SS, Qian Y, Chen F, Huang C, Vallyathan V, Castranova V, Shi X. Poster 
presented in 3rd International Conference on Oxygen/Nitrogen Radicals: Cell Injury 
and Disease, Morgantown, WV, 2002. 
 
Role of lung surfactant in phagocytic clearance of apoptotic cells by macrophages 
during the development of pulmonary inflammation and fibrosis. Wang L, Scabilloni 
JF, Rojanasakul Y, Antonini J, Zhang Z, Castranova V, and Mercer RR. Poster 
presented in Experimental biology meeting. New Orleans, LA, 2002 
 
Arsenite modulation of the integrity of actin filaments and the increase in cell motility 
may be mediated through CDC42. Qian Y, Zhang Z, Flynn D, Shi X. Poster 
presented in Experimental biology meeting. New Orleans, LA, 2002 
 
Presented PPRB branch seminar entitled “Vanadate induces cell growth arrest through 
MAP kinase and ROS” at NIOSH, Morgantown, WV, 2001. 
 
216
Presented seminar entitled “The role of phosphoinositide-3 kinase in vanadate-
induced cell cycle regulation” at West Virginia University, Morgantown, WV 2001 
 
Vanadate-induced cell growth regulation and the role of reactive oxygen species. 
Zhang Z, Huang C, Li J, Leonard SS, Lanciott R, Butterworth L, Shi X. 8th Oxygen 
Society Annual Meeting, San Diego, CA, 2000 
 
